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Abstract 
 
Embryonic Stem cells (ESCs) have the unique characteristics of self-renew 
and differentiate into all the cells derived from the three germ layers. These 
properties make them a limitless source of specialized cells for replacement 
therapies. However, the knowledge of the mechanisms controlling ESC 
differentiation into lineage-specific derivatives is necessary before using them 
for therapeutic purposes. Extracellular signalling, as that of bone 
morphogenetic protein 4 (BMP4), plays an important role in maintaining 
ESCs in undifferentiated state and in regulating the lineage commitment. 
Recently, it was identified a transmembrane protein, named Dies1, which 
suppression blocks ESC differentiation by interfering with the BMP4 
signalling. Over the past few years, it has become evident the involvement of 
miRNAs in the ESC fate. Thus, we investigated whether a physiological 
modulation of Dies1 level by miRNAs could be a mechanism regulating ESC 
choice between pluripotency and differentiation. We demonstrated that miR-
125a and miR-125b control Dies1 expression targeting its 3’ UTR. Their 
overexpression impairs ESC differentiation, maintaining the cells in the 
epiblast state. This effect is due to a reduction of BMP4 signalling and a 
concomitant increase of Nodal/Activin pathway. This phenotype recapitulates 
that of Dies1 KD ESCs and is mediated by Dies1 suppression. Moreover we 
found that Dies1 is associated with BMP4 receptor complex and that BMP4 
itself induces the expression of miR-125a at transcriptional level. This 
miRNA, in turn, controls BMP4 activity through Dies1 regulation. These 
results show that a feedback loop exists to set ESC sensitivity to BMP4, and it 
is mediated by miR-125a and Dies1. Interestingly,  we found that miR-125b, 
opposite to miR-125a, is not directly regulated by Transforming Growth 
Factor-β (TGF-β) signals. These results demonstrate a new role of miR-125a 
and miR-125b in the regulation of the transition of ESCs to the epiblast stage, 
working on the control of TGFβ signalling. 
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Introduction 
 
The discovery of  Embryonic stem cell (ESC) potential to self-renew and to 
differentiate in all the three primary germ layer derivatives opens new hope 
for regenerative medicine. More recently, it was discovered that both mouse 
and human somatic cells can be reprogrammed to a pluripotent state that 
resembles that of ESCs, by ectopic expression of four transcription factors, 
Oct4, Sox2, c-Myc and KLF4 (Takahashi, et al., 2006). These ES-like 
pluripotent cells are known as induced pluripotent stem cells (iPSCs). This 
finding makes possible to take somatic cells from adults, reprogram them in 
vitro and differentiate in clinically relevant cell types. In this way the idea of 
cell transplantation-based regenerative medicine is closer to reality, with the 
big advantage of overcoming the immunogenicity and ethical controversy of 
ESCs (Watabe, et al., 2009). It is evident that ESCs represent a limitless 
source of cells useful for treatment of degenerative diseases and replacement 
therapies, but their plasticity makes them difficult to be manipulated. For 
these clinical applications, it is necessary to deeply understand the cellular 
and molecular mechanisms regulating ESC pluripotency and lineage 
commitment. Despite their complexity, ESCs have the big advantage to 
recapitulate in vitro the crucial steps of embryo development, allowing a more 
detailed study of cell fate decisions. 
During pre-implantation development, the morula is made of two layers of 
cell: the trophectoderm (outside) and the inner cell mass (ICM) (inside). The 
trophectoderm gives rise to the placenta while the ICM will give rise to the 
developing embryo and associated yolk sack, allantois and amnion (Rossant, 
et al., 2004). These two cell populations express specific marker genes, such 
as Cdx2 and Eomes for trophoblast (Strumpf, et al., 2005) and Oct4 (Nichols, 
et al., 1998) and Nanog (Chambers, et al., 2003) (Mitsui, et al., 2003) for the 
ICM. At the blastocyst stage, the ICM is localized to one side of the cavity 
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known as the blastocoels, formed by fluids secreted by the trophectoderm. At 
this point, two lineages are segregated from the ICM: the primitive endoderm 
or hypoblast and the epiblast. The primitive endoderm will only contribute to 
extraembryonic tissues  and it is distinguished by the expression of Gata4 and 
Gata6 markers. The epiblast is responsible for the generation of the three 
primary germ layers (Niwa, 2007) and it will express the pluripotency 
markers Oct3/4 and Nanog. During this process, epiblast cells egress through 
the primitive streak (PS), a transient structure that will form the posterior end 
of the embryo. The first mobilized epiblast cells pass through the PS and give 
rise the extraembryonic mesoderm, that will form the allantois, the amnion 
and the hematopoietic, endothelial and vascular smooth muscle cells of the 
yolk sac (Figure 1). In the following steps of gastrulation, cells migrate 
through the most anterior part of PS to generate the mesoderm, characterized 
by the expression of the specific marker Brachyury (T), and the definitive 
endoderm. The mesoderm will form the hematopoietic, vascular, cardiac, and 
skeletal muscle lineages, while the endoderm will develop towards organs 
like the stomach, the liver, the pancreas, the lungs etc. The ectoderm derives 
from the anterior region of the epiblast that doesn’t enter the primitive streak, 
and will form the skin and the neural lineages (Murry, et al., 2008).  
To further define all the processes and stimuli that specify ESC fate, it is 
possible to study, in vitro, the embryonic development, using ESCs derived 
from the inner cell mass (ICM) of the pre-implantation embryo. These cell 
retain their pluripotency in vitro, being able to generate cells of all lineages, 
including the germ line, after being introduced into host blastocysts (Keller, 
1995). More recently, another pluripotent stem cell population was 
discovered. It was isolated from the post-implantation epiblast tissue and so 
named Epiblast stem cell (EpiSC) (Brons, et al., 2007). These cells are still 
pluripotent and can self-renew: indeed, they have the ability to generate 
derivatives of all three germ layers both during in vitro differentiation and in 
vivo teratoma formation, but they are inefficient in the formation of chimeras. 
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EpiSCs still express the pluripotency factors Oct3/4 and Nanog, but they have 
also a peculiar gene expression profile and a different dependence from 
extracellular signalling for maintenance. EpiSCs require high level of Activin 
and Fgf2 signalling, but not LIF and BMP4 as for ESCs. Moreover they have 
already undergone X-inactivation, suggesting a more advanced developmental 
stage (Chou, et al., 2008). Indeed, EpiSCs are said to be already ‘primed’ to 
differentiation, while ESCs are in a ‘naïve’ state. 
 
 
 
 
Figure 1. A schematic view of mouse preimplantation development.  
(A) Pluripotent stem cells (green) are imaged in a morula as the inner cells, which (B) then 
form the inner cell mass (ICM) of the blastocyst. (C) After giving rise to the primitive 
endoderm on the surface of the ICM, pluripotent stem cells then form the epiblast and start 
to proliferate rapidly after implantation. (D) They then form the primitive ectoderm, a 
monolayer epithelium that has restricted pluripotency which goes on to give rise to the 
germ cell lineage and to the somatic lineages of the embryo. Certain key transcription 
factors (blue) are required for the differentiation of the various embryonic lineages (Niwa, 
2007). 
 
ESCs can differentiate going through an epiblast state. Three different 
protocols have been developed to control ESC differentiation in a specific 
lineage, using the proper culture conditions (Figure 2) (Keller, 2005 ).  With 
the first method, ESCs are allowed to aggregate and form three-dimensional 
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colonies known as embryo bodies (EBs) (Doetschman, et al., 1985). They 
form a multidifferentiated structure in which the developmental program of 
ICM/epiblast cells is reactivated. Cellular differentiation proceeds on a 
schedule similar to that in the embryo but in the absence of proper axial 
organization or elaboration of a body plan (Doetschman, et al., 1985). With 
the second method, ESCs are cultured directly on stromal cells, and 
differentiation takes place in contact with these cells. It is also possible to use 
a medium conditioned by other cell types in which culture ESCs (Nakano, et 
al., 1994). The disadvantage of this method is that factors produced by 
supportive cells may influence the differentiation of ESCs to undesired cell 
types. The third protocol of differentiation is based on growing ESCs in a 
monolayer on extracellular matrix proteins (Nishikawa, et al., 1998). In this 
way, the influence of supportive stromal cells can be minimized. 
 
 
 
Figure 2. Three different protocols used for ESC differentiation. 
(Keller, 2005 ) 
 
Clearly, the ability of ESCs to give rise to a variety of different cell types 
suggests the complex network of regulatory mechanisms that control this 
process. To date a lot of studies have highlighted the mechanism of 
maintenance of ESC pluripotency.  In particular, a strong contribution is 
given by the coordinated action of extracellular signalling, transcription 
factors, epigenetic modifications and, more recently, miRNAs. 
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1. Extracellular signalling 
Initially, mESCs were derived and cultured on a layer of mitotically 
inactivated fibroblasts in serum-containing medium (Evans, et al., 1981). It 
was thought that fibroblasts support self-renewal providing trophic factors 
and acting as a feeder. To date, it is known that ESCs depend on the 
signalling of growth factors to maintain pluripotency. The most important 
extracellular signals controlling self-renewal and differentiation are LIF, 
TGF-β and WNT. However, the requirement for a particular signal may be 
context-dependent and a specific growth factor can have different role 
depending on the developmental stage of ESCs. For example, BMP4 normally 
induces differentiation of ESCs, but behaves as a self-renewal signal in the 
presence of LIF (Zhang, et al., 2010). It indicates that the pluripotency is a 
more complex mechanism controlled not simply by one or more extracellular 
signals, but also by their synergic action with transcription factors. 
 
1.1 The LIF pathway and its connection to ERK1/2 signalling  
The addition of leukemia inhibitory factor (LIF) to serum-containing medium 
is necessary to support self-renewal. LIF is an IL-6 family cytokine that 
signals through a receptor complex made of the transmembrane protein gp130 
and the low-affinity LIF receptor β (LIFRβ) (Boulton, et al., 1994). Ligand 
binding induces the receptor dimerization and the activation of two main 
signalling pathways. Through its intracellular domain, gp130 recruits and 
activates the Janus-associated tyrosine kinase (JAK), which in turn 
phosphorylates tyrosine residues on gp130. This modification generates a 
binding sites for the signal transducer and activator of transcription 3 
(STAT3) that is substrate for tyrosine phosphorylation mediated by JAK. 
Following phosphorylation, the transcription factor STAT3 dimerizes and 
translocates to the nucleus where it modulates transcription of target genes 
(Darnell, et al., 1994) (Figure 3). It was demonstrated that activation of 
STAT3 is required for self-renewal, since it can support stemness 
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maintenance also in the absence of exogenous LIF (Matsuda, et al., 1999). 
STAT3 exerts this function acting on target gene expression. A well 
characterized target of STAT3 is cMyc. Indeed, sustained cMyc expression 
can maintain stemness and inhibit ESC differentiation induced by LIF 
withdrawal (Cartwright, et al., 2005). Among the other identified targets of 
STAT3, a relevant role is played by Socs3 and Klf4. The first one was 
demonstrated to be a negative regulator of LIF signalling, acting through a 
negative feedback loop. Instead, Klf4 can promote ESC self-renewal, since its 
overexpression in ESCs leads to the block of differentiation (Li, et al., 2005). 
On the other hand, phosphorylated gp130 can associate to SH2 domain 
containing proteins including Shp2 and Grb2. They, in turn, recruit SOS 
protein activating Ras and the mitogen activated protein kinase (MAPK) 
cascade. In particular, the effectors of this signalling are the extracellular 
signal-regulated protein kinase-1 and -2 (ERK1/2), that can enter in the 
nucleus where activate various TFs (Marais, et al., 1993). The role of ERK1/2 
in ESCs is to negatively control self-renewal as demonstrated by the finding 
that preventing the activation of ERK1/2 by LIF, ESC self-renewal is 
enhanced (Burdon, et al., 1999). Moreover the ERK signalling promotes the 
transition of ESCs in a stage corresponding to the egg cylinder epiblast, 
responsive to inductive cues for germ layer segregation (Kunath, et al., 2007) 
(Stavridis, et al., 2007).  
This result indicates that LIF signalling can activate two pathways giving 
opposite effects on self-renewal determining a balance between STAT3 and 
ERK1/2 signalling. The preferential activation of one way respect the other 
will define the choice between self-renewal and differentiation. Clearly, this is 
achieved by the cooperation of LIF signalling both with the other signalling 
and the transcriptional machinery.  
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Figure 3. Schematic representation of the LIF-pathway 
(Grafl, et al., 2011) 
 
 
1.2 TGF-β superfamily signalling 
Ying and collaborators observed that the presence of serum in the culture 
medium is necessary for self-renewal. Indeed, ESCs undergo neural 
differentiation simply by removing serum from the medium, even in presence 
of LIF. This finding suggests that other factors contained in the serum are 
crucial to inhibit neural differentiation sustaining self-renewal. In particular, 
they demonstrated that addition of BMP4 to serum-free medium containing 
LIF could support self-renewal (Ying, et al., 2003). BMP belongs to the 
transforming growth factor-β (TGF-β) superfamily, together with TGFs, 
Nodal, Activin. TGF-β ligands regulate different processes during 
embryogenesis, as the establishment of the body plan in the embryo (Wu, et 
al., 2009). They also play a central role in maintenance of ESC identity as 
proven by the observation that Smad4 deficient mouse embryos display 
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delayed outgrowth of the inner cell mass (Sirard, et al., 1998). At cellular 
level the TGF-β system is involved in the regulation of cell proliferation and 
growth arrest, pluripotency and differentiation, cell survival and apoptosis. 
These activities depend on cellular context, in particular on the stage of target 
cell, the local environment, and the identity and dosage of the ligand 
(Seuntjens, et al., 2009).  
TGF-β ligands signal through serine/threonine kinase receptors, made of 
heterodimers of type I and type II receptors. In mammals, there are 7 type I 
receptors and 5 type II receptors, that exist as homodimers on cell surface in 
absence of the ligand. The binding of the ligand to one of the two types of 
receptors induces the association of type I and II dimers, forming an 
heterotetrameric complex. The ligand can bind preferentially one of the two 
receptors. For instance, TGF-βs and Activins bind to type II receptors, 
whereas BMPs associate to type I homodimers before forming a complex 
with type II receptors. However, following ligand binding, type I receptor is 
activated by phosphorylation from type II receptor and can now recruit 
receptor-regulated Smads (R-Smads). Each type I receptor can activate only a 
subset of R-Smads, and this peculiarity generate two distinct pathways among 
the TGF-β superfamily signalling. In particular, the ligands of BMP/GDF 
family signal through R-Smads as Smad1, Smad5 and Smad8, activated by 
Alk1, Alk2, Alk3 and Alk6 type I receptors. Instead, the ligands of TGF-
β/Nodal/Activin family bind to Alk4, Alk5 and Alk7 type I receptors 
activating R-Smads as Smad2 and Smad3. Once recruited to the receptor 
complex, R-Smads are phosphorylated on serine residues by type I receptor. 
This modification allow them to form homodimers which complex with 
Smad4, the common mediator shared by both BMP and Nodal/Activin 
pathway. This complex then translocates to the nucleus where regulates the 
expression of target genes specific of each branch of TGF-β superfamily, so 
determining a peculiar cellular response (Schmierer, et al., 2007) (Figure 4).  
15 
 
This intricate signalling needs to be finely regulated. A first regulation occurs 
at level of ligand-receptor interaction. For example, some extracellular 
inhibitory proteins exist that sequester the ligands from the binding to their 
receptor (Follistatin, Chordin, Noggin, Caronte, Cerberus) (Massagué, 2000). 
In contrast, several co-receptors have been identified as necessary for ligand 
binding to the receptor acting as co-activator, such as Betaglycan, Endoglin, 
DRAGON and the EGF-CFC (Epidermal Growth factor–Cripto–FrL1–
Cryptic) family member Cripto (Feng, et al., 2005). Dragon was identified as 
a BMP co-receptor, while Cripto is necessary for nodal signalling. The TGF-β 
superfamily pathways are modulated also through a negative feedback loop 
involving the induction of the inhibitory Smads (I-Smads), Smad6 and 
Smad7, by BMP and TGF-β (Schmierer, et al., 2007). Ubiquitin-proteasome 
mediated degradation of Smads is another way to control R-Smad levels and 
the sensitivity of cells to incoming signals. Indeed, Smurf1 (Smad 
ubiquitination-regulatory factor 1) and Smurf2, belonging to the family of 
HECT (homologous to the E6-AP carboxy terminus) E3 ubiquitin ligases, 
antagonize TGF-β family signalling by interacting with R-Smads and 
targeting them for degradation. Particularly, Smurf1 interacts with Smad1 and 
Smad5, thereby affecting BMP responses, whereas Smurf2 interacts with 
different R-Smads, allowing interference with BMP and TGF-β/activin 
signalling (Derynck, et al., 2003). 
 
1.2.1 BMP 
The relevance of BMP in ESCs is demonstrated by the suppression of its 
receptor Alk3 (also known as BMPRIA). Mice homozygous for this null 
allele died at embryonic day 8.0 (E8.0) without mesoderm formation. Mishina 
and collaborators proposed that the primary defect caused by this mutation 
could be in the regulation of epiblast-cell proliferation of egg cylinder-stage 
embryos (Mishina, et al., 1995). 
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Figure 4. Core signalling in the mammalian TGFβ–SMAD  pathways 
Binding of ligands to type II receptors and recruitment of type I receptors activate  the 
signalling. The phosphorylation of type I receptors allows the recruitment of R-SMADs 
that are in turn phosphorylated. TGF-β1, Activin and Nodal signal through type I receptors 
Alk4, 5 and 7 binding to induce SMAD2,3 phosphorylation, whereas BMPs bind to Alk1, 
2, 3 and 6 that induce SMAD 1,5,8 phosphorylation. Once activated, R-Smads associate to 
the common mediator SMAD4 and translocate to the nucleus where modulate gene 
expression (Schmierer, et al., 2007). 
 
 
BMP exerts its function inducing the expression of several target genes. In 
mouse ESCs and in various cell types, the classic BMP targets are the 
Inhibitor of differentiation (Id) family proteins. IDs suppress precociously 
expressed neurogenic basic helix-loop-helix (bHLH) transcriptional activators 
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and thus suppress neural differentiation, leading to strengthened self-renewal 
(Li, et al., 2013). Ectopic expression of Id1, Id2 and Id3 in ESCs maintains 
self-renewal in serum-free culture, even remaining LIF-dependent. This result 
indicates that the contribution of BMP/Smad in stemness maintenance is to 
induce Id expression. 
BMP signalling cooperates with LIF and ERK pathway in determining ESC 
fate. In neuroepithelial cells, gene expression is regulated by a ternary 
transcription factor complex made of Smad, STAT3 and p300 (Nakashima, et 
al., 1999) (Sun, et al., 2001). Ying demonstrated that also in ESCs STAT3 
associates with Smads, driving the specificity of target genes. He suggested 
that the formation of the STAT3/Smad1 complex may play a key role by 
limiting the availability of active Smad1 for partnering with other cofactors. 
Effective Smad action may be restricted by STAT3 to a subset of targets, 
notably Id genes, that are either receptive to STAT3/Smad complex or are 
inducible by low levels of Smad. In this scenario, withdrawal of gp130 
stimulation would release active Smad to complex with transcriptional 
coactivators that drive recruitment to differentiation genes (Ying, et al., 2003). 
An evidence of cooperation between BMP and ERK pathways comes from 
the finding that BMP can induce the dual-specificity phosphatase 9 (DUSP9, 
also known as MKP-4), an ERK-specific phosphatase, inhibiting ERK 
activity. In this way, extrinsic BMP stimulus affects intrinsic ERK activity 
through DUSP9 (Li, et al., 2012).  
Recently, it was found the existence of a BMP4-sensitive window during 
mouse ESC neural commitment. Cells at this stage correspond to the epiblast 
of the egg cylinder, and can be maintained as ESC-derived EpiSCs (ESD-
EpiSCs). Moreover BMP4 was demonstrated to have an inhibitory role during 
ESC neural differentiation, acting at two different phases. First of all, it 
inhibits the derivation of ESD-EpiSCs (ESC derived-Epiblast Stem Cells) 
from mouse ESCs; and second, it suppresses the neural commitment of ESD-
EpiSCs and promotes their non-neural differentiation (Zhang, et al., 2010).  
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1.2.2 Dies1, a new regulator of BMP4 signalling 
In 2010, Aloia and colleagues, in the laboratory where I carried out my 
research project, discovered a new gene involved in BMP4 signalling. A 
screening based on RNA interference to find molecules regulating ESC fate 
allowed them to identify an unknown gene named Dies1 (Differentiation of 
ES cells 1) (Aloia, et al., 2010). Dies1 KD ESCs were not able to differentiate 
either toward neurons or cardiomyocytes. Even in forced differentiation 
conditions, Dies1 knockdown induces maintenance of the stemness markers 
of ESCs, strongly suggesting the important role of Dies1 in ESC 
differentiation. Dies1 encodes a transmembrane protein containing a signal 
peptide and a V-type Ig-like domain in the extracellular N-terminus region. In 
this region three possible Asn-glycosylation sites are present, indeed the 
glycosylation of Dies1 was addressed. Aloia et al. found that Dies1 
downregulation reduces the induction of Id proteins (BMP4 pathway) 
increasing Nodal/Activin targets, whereas it doesn’t affect LIF pathway. They 
concluded that this unbalance between BMP4 and Nodal/Activin is 
responsible for the phenotype observed upon Dies1 knockdown. This study 
demonstrated an involvement of Dies1 in the regulation of ESC 
differentiation and in the BMP4 signal transduction machinery, through the 
modulation of extracellular signalling (Aloia, et al., 2010).  
Given the importance of BMP4 signalling in ESC fate, this work opens a new 
field of study aimed at unraveling of the molecular mechanisms in which 
Dies1 takes part together with BMP4 in the definition of ESC pluripotency. 
 
 
1.2.3 Nodal/Activin 
Nodal and activin contribute to the maintenance of mESC identity, as 
demonstrated by the reduction of pluripotent cell propagation in early 
embryogenesis of many Nodal-related mutant mice. For example, Nodal null 
mice display very little Oct3/4 expression and substantial reduction in the size 
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of epiblast cell population (Conlon, et al., 1994) (Robertson, et al., 2003). 
Smad2 knockout mouse embryos fail to form mesoderm and endoderm due to 
defects in primitive streak specification after implantation at 6.5 dpc, closely 
phenocopying Nodal mutants (Nomura, et al., 1998).  
In cell culture, the importance of activin-Nodal-TGF-β signalling was 
highlighted by the observation that its inhibition by Smad7 expression or by 
the specific inhibitor SB-431542 dramatically decreases mESC propagation. 
In clonal cultures with serum free medium, supplementation of recombinant 
Nodal and activin increased the ESC proliferation ratio with maintenance of 
the pluripotent state. These findings indicate that Nodal and activin signalling 
promotes mESCs propagation with maintenance of pluripotent state in serum-
free conditions (Ogawa, et al., 2007). 
Nodal and Activin exert their function modulating the expression of a specific 
subset of genes. It was proposed that a graded Nodal/Activin signalling could 
determine a different intracellular response. In particular extracellular 
signalling gradients are translated into a gradient of Smad2 phosphorylation 
that can activate different target genes in a dose-dependent manner. An 
exchange of transcriptional co-partners allows the shifting of the pSmad2 
transcriptional complex to different target gene subsets. The consequence is 
that a relatively modest stimulation with Activin leading to a physiological 
increase in Smad2 phosphorylation eventually drives mesendodermal 
differentiation, while the inhibition by SB-431542 resulting in a decrease of 
pSmad2 is able to promote trophectoderm cell fates (Lee, et al., 2011). 
 
 
1.3 Wnt Signalling 
Wnt signalling has been implicated in ESC fate, since it can interact with LIF, 
regulating STAT3 transcription (Hao, et al., 2006) and with BMP4, mediating 
cyclin D1 induction (Lee, et al., 2009). The central mediator of Wnt signalling 
is β-catenin. In absence of ligands, β-catenin is phosphorylated by two 
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kinases, casein kinase 1a (CK1a) and glycogen synthase kinase 3β (Gsk3β), 
which are associated with the so-called ‘destruction complex’, formed by 
APC and axin. Upon phosphorylation, β-catenin is ubiquitinated and degraded 
via the proteasome pathway (Wray, et al., 2012). The kinase responsible for 
β-catenin phosphorylation is GSK3β, so direct inhibition of GSK3β mimics 
Wnt signalling (Patel, et al., 2004). The identification of a novel GSK3β 
inhibitor, BIO, as a sustenance to stemness (Sato, et al., 2004) has given rise 
to the idea that Wnt signalling can support the self-renewal of pluripotent 
cells.  
Activation of the signalling occurs when Wnt ligands bind to receptor 
complex, composed of a serpentine receptor of the frizzled family and a 
coreceptor of the low-density lipoprotein receptor related protein family, 
Lrp5/6. The interaction between the ligand and its receptor complex results in 
the dissociation of the destruction complex, allowing β-catenin to translocate 
into the nucleus. In the nucleus, β-catenin acts as a coactivator for 
transcription factors of the Tcf/Lef (T cell factor/ lymphoid enhancing factor) 
family (Wray, et al., 2012) (Figure 5). The member of this family, Tcf3, has a 
central role in Wnt signalling in ESCs: indeed, it can repress Nanog gene 
expression (Pereira, et al., 2006). A genome-wide analysis revealed that Tcf3 
co-occupies the ESC genome with the pluripotency transcription factors Oct4 
and Nanog. Moreover, it was found that, under standard culture conditions, 
Tcf3 may exist in an activating or repressive complex, but is predominantly in 
a repressive complex promoting differentiation. Following Wnt stimulation, 
the complex is converted to an activating form that promotes pluripotency. In 
this way the Wnt pathway, through Tcf3, influences the balance between 
pluripotency and differentiation by bringing developmental signals directly to 
the core regulatory circuitry of ESCs (Cole, et al., 2008). 
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Figure 5. Schematic representation of Wnt pathway 
In the absence of Wnt ligands (right panel), the presence of secreted inhibitors (Wnt 
inhibitory factor 1 (WIF1) and soluble frizzled-related proteins (sFRPs)) or the inhibition 
of LRP co-receptors (by secreted Dickkopf protein (DKK1)), the destruction complex, 
containing the core components axin, APC and GSK3β, recruits and phosphorylates β-
catenin. Phosphorylated β-catenin is rapidly ubiquitinated and degraded by proteasome. 
When Wnt ligands bind to frizzled receptors (left panel), LRP co-receptors are 
phosphorylated by casein kinase 1γ (CK1γ) and glycogen synthase kinase 3β (GSK3β). 
The formation of a β-catenin ‘destruction complex’ is prevented and β-catenin can 
translocate to the nucleus. Nuclear β-catenin interacts with the T-cell-specific 
factor/lymphoid enhancer-binding factor (TCF/LEF) transcription factors to regulate target 
gene transcription (Arnold, et al., 2009). 
 
 
2. Transcriptional networks 
The property of pluripotency is conferred by the expression of a set of 
transcription factors, preventing differentiation. The master genes of 
pluripotency are Oct3/4, Sox2 and Nanog. 
Oct3/4 (encoded by the Pou5f1 gene) is a member of POU-domain 
transcription factor family expressed in mouse blastomeres, epiblast cells and 
primordial germ cells (PGCs). Its crucial role in pluripotency was highlighted 
by the observation that mouse ESCs lacking Oct3/4 differentiate into 
trophectoderm, indicating that Oct3/4 is required to inhibit differentiation in 
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this specific lineage (Niwa, et al., 2000). Further experiments showed that this 
inhibition is due to the interaction of Oct3/4 with Cdx2 (Niwa, et al., 2005 ). 
Oct4 expression is continuously required for the maintenance of pluripotency 
but its expression is not sufficient, suggesting that interaction with other 
transcription factors is critical to Oct4 function (Niwa, et al., 2000). Among 
the Oct3/4 interactors, it was found Sox2. Sox2 has an high-mobility group 
box DNA-binding domain and it is expressed in the ICM and the 
extraembryonic ectoderm of pre-implantation blastocysts. It is known that 
Sox2 co-operates with Oct3/4 activating its target genes (Tomioka, et al., 
2002). Moreover, Oct3/4 and Sox2 complex regulates their own expression 
(Chew, et al., 2005): Oct3/4 and Sox2 binding sites are located in the 
promoter regions of these two genes, generating a feedback loop to control 
the pluripotency state. To strongly support that pluripotency is the result of a 
network of transcriptional factors, it was demonstrated that Oct3/4 and Sox2 
complex controls the expression of another key pluripotency gene, Nanog 
(Rodda, et al., 2005).  
Nanog is an homeobox transcription factor essential for ESCs: indeed, 
Nanog-overexpressing ESCs are maintained in a pluripotent state even in 
absence of LIF (Chambers, et al., 2003). Moreover, Nanog-null ESCs were 
found to acquire a parietal endoderm-like morphology and express high level 
of Gata6 marker (Mitsui, et al., 2003), indicating that Nanog can act as Gata6 
repressor. A putative Nanog-binding site has also been identified in the 
enhancer region of Gata6 but has yet to be demonstrated to bind Nanog 
(Mitsui, et al., 2003). The impairment of primitive endoderm differentiation is 
not the only effect of Nanog. It was found that also neuronal differentiation 
induced by BMP4 and LIF removal is impaired by Nanog (Ying, et al., 2003). 
Finally, Nanog can interact with Smad1 repressing Brachyury (T), a 
mesoderm-specific gene (Suzuki, et al., 2006). All together, these studies 
indicate the importance of Nanog in the maintenance of ESC self-renewal, 
since it blocks the primitive endoderm, neuronal and mesodermal 
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differentiation. Recent studies indicated that Nanog is not expressed 
homogenously in ESCs: there is a sub-population of pluripotent ESCs not 
expressing Nanog. The absence of Nanog doesn’t affect the pluripotent state 
and it is dispensable for the maintenance of ES cells (Chambers, et al., 2007). 
Chambers suggested that low levels of Nanog represent a “window of 
opportunity” in which ESCs can differentiate, if subject to specific 
environmental or intrinsic perturbations. 
To further explore the transcription network of pluripotency, chromatin 
immunoprecipitation (ChIP) experiments have been performed to identify 
transcriptional targets of the three transcription factors. Genome wide analysis 
revealed that a lot of promoters occupied by one transcription factor would 
also be occupied by the others (Loh, et al., 2006). This suggests that they 
cooperate in the positive and negative regulation of target genes controlling a 
cascade of pathways that are intricately connected to govern pluripotency, 
self-renewal, genome surveillance and cell fate determination (Loh, et al., 
2006) (Figure 6). Nanog expression is positively regulated by the members of 
the Kruppel-like transcription factors family, Klf2, Klf4 and Klf5, controlling 
ESC self-renewal (Jiang, et al., 2008) (Hall, et al., 2009). Klf4 is one of 
transcription factors used by Yamanaka to reprogram somatic cells to a 
pluripotent state (Takahashi, et al., 2006), and Klf2 and Klf5 are able to 
substitute for Klf4 function in the reprogramming (Nakagawa, et al., 2008). 
This indicates a redundant function for Klf2, Klf4 and Klf5. In our laboratory, 
it was demonstrated that Klf5 has unique functions. In absence of LIF, Klf5 
downregulation induces ESC differentiation, whereas its ectopic expression 
maintains ESC pluripotency (Parisi, et al., 2008). The evidence of  a specific 
requirement of Klf5 in early embryogenesis is given by the finding that Klf5 
knockout mice show developmental defects at the blastocyst stage (Ema, et 
al., 2008). To better define the contribution of Klf5 to stemness maintenance, 
Parisi and colleagues identified primary targets of Klf5 in ESCs, by 
combining genome-wide chromatin immunoprecipitation and microarray 
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analysis. They found that Klf5 controls genes essential in ESCs such as Tcl1, 
BMP4 and Nr0b1, and thus it may be required to maintain pluripotency by 
activating expression of these self-renewal promoting genes and by 
simultaneously inhibiting expression of differentiation promoting genes such 
as TGFβ2, Otx2, Pitx2 and GDNF. Moreover many Klf5 targets are not 
regulated by Klf2 and Klf4 indicating the specificity of Klf5 in ESC self-
renewal (Parisi, et al., 2010). 
 
 
Figure 6. A transcription factor network to control ESC self-renewal and 
differentiation.  
Transcription factor networks for pluripotent stem cells (green), trophectoderm (yellow) 
and primitive (extraembryonic) endoderm (blue). Positive-feedback loops between Oct3/4, 
Sox2 and Nanog maintain their expression to promote continuous ES cell self-renewal. 
Cdx2 is autoregulated and forms a reciprocal inhibitory loop with Oct3/4. A combination 
of positive-feedback loops and reciprocal inhibitory loops converts continuous input 
parameters into a bimodal probability distribution, resulting in a clear segregation of these 
cell lineages (Niwa, 2007). 
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3. Epigenetic modifications 
Epigenetic regulation of gene expression is mediated in part by post-
translational modifications of histone proteins, which in turn modulate 
chromatin structure (Jenuwein, et al., 2001). The core histones H2A, H2B, 
H3, and H4 are subject to many different modifications, including acetylation, 
methylation, and phosphorylation. The two more interesting histone 
modifications are histone H3 methylation on lysine 4 (Lys4) and lysine 27 
(Lys27) since they are catalyzed, respectively, by trithorax and Polycomb-
group proteins, which have key developmental functions. Lys4 methylation 
positively regulates transcription by recruiting nucleosome remodelling 
enzymes and histone acetylases, while Lys27 methylation negatively 
regulates transcription by promoting a compact chromatin structure 
(Bernstein, et al., 2006). 
ESCs possess highly dynamic, decondensed chromatin (Meshorer, et al., 
2006) and an interesting pattern of chromatin modifications. Large regions of 
the repressive histone mark, trimethyl histone 3 lysine 27 (H3K27me3), were 
found to harbour smaller regions of the active mark H3K4me3 and were 
termed ‘bivalent domains’ (Azuara, et al., 2006) (Bernstein, et al., 2006) 
(Figure 7). The coexistence of these marks suggests that lineage-specific 
genes are primed for expression in ES cells but are held in check by opposing 
chromatin modifications (Azuara, et al., 2006). Furthermore, the bivalent 
domains were enriched in regions encoding transcription factors that were not 
expressed or expressed at low levels. A recent study has demonstrated a link 
between the core transcription factors of pluripotency and epigenetic 
regulators (Loh, et al., 2006). Oct4 regulates the transcription of the H3K9 
demethylases Jmjd1a and Jmjd2c. The first demethylates H3K9me2 while the 
second demethylates H3K9me3. Interestingly, Jmjd1a or Jmjd2c depletion 
leads to ES cell differentiation, which is accompanied by a reduction in the 
expression of ES cell-specific genes and an induction of lineage marker 
genes. Jmjd1a demethylates H3K9Me2 at the promoter regions of Tcl1, 
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Tcfcp2l1, and Zfp57 and positively regulates the expression of these 
pluripotency-associated genes. Jmjd2c acts as a positive regulator for Nanog, 
which encodes for a key transcription factor for self-renewal in ES cells. 
These experiments link the activity of Oct4 targets to modulation of the 
chromatin to facilitate expression of pluripotency-associated TFs (Niwa, 
2007). It was found that ESCs can tolerate quite severe disruptions to their 
epigenetic machinery while retaining the characteristics of pluripotency 
(Pasini, et al., 2007) (Montgomery, et al., 2005). This observation induced 
Niwa to propose that epigenetic processes are likely to be responsible for the 
execution of the pluripotent program, which is itself established by the 
transcription factor network, rather than for the maintenance of pluripotency 
per se (Niwa, 2007). 
 
Figure 7. Characteristics of the pluripotent epigenome. 
Small regions of perinuclear heterochromatin exist, but most of the chromatin exists as 
euchromatin, bearing histone marks associated with transcriptional activity. The 
hyperdynamics of chromatin proteins (green) might contribute to the maintenance of 
euchromatin. Bivalent domains are also a feature of the pluripotent epigenome, in which 
active histone marks (such as H3K4me) are flanked by transcriptionally repressive histone 
marks (such as H3K9me) (Niwa, 2007). 
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4. MicroRNAs as regulator of ESC fate 
In the last years the role of miRNAs in regulating many biological processes 
became evident (Bushati, et al., 2008) (Houbaviy, et al., 2003). Since 
miRNAs can modulate at post-trascriptional level the expression of different 
target genes, they represent a fine mechanism to control ESC differentiation 
program. 
Biogenesis of miRNAs is a multistep process initiated in the nucleus. 
miRNAs are transcribed by RNA polymerase II as long, capped and 
polyadenylated primary transcript (pri-miRNA) of 60-100 nucleotide in 
length, to form a stem loop structure. The pri-miRNAs are cleaved in the 
nucleus by the Microprocessor complex, containing the RNase III enzyme 
Drosha and the double-stranded RNA binding domain (dsRBD) protein 
DGCR8 at the base of the stem loop to produce 60-70 nt long precursors (pre-
miRNA). The pre-miRNAs have to move to the cytoplasm by using a nuclear 
transport receptor complex, exportin-5–RanGTP. There, they are recognized 
by an heterotrimeric complex composed of the RNase Dicer, the double-
stranded RNA-binding protein TRBP, and Argonaute (Ago) proteins. Dicer 
further cleaves pre-miRNAs 22 nucleotides from the Drosha cleavage site, 
thereby generating a mature miRNA duplex. This complex identifies the 
guide strand of the RNA duplex and separates the two strands. The guide 
strand of the miRNA remains associated with the Ago protein in the miRNA-
induced silencing complex (miRISC), which in turn recognizes target mRNAs 
based on complementarity between the miRNA and the mRNA target. 
Nucleotides 2–7 (from the 5’ end) of the mature miRNA, also called the 
‘‘seed’’ motif, form the critical region for target mRNA recognition that 
hybridizes nearly perfectly with the target (Martinez, et al., 2010). Without a 
perfect match between the two RNA molecules, the target is not cleaved, but 
its translation is repressed (Figure 8). Translational repressed mRNA-protein 
complexes can localize in cytoplasmic foci named P-bodies (Liu, et al., 2005). 
Here, translational repressed mRNA could stay in oligomeric structures for 
28 
 
storage or could form a complex with decapping enzymes and cap-binding 
proteins that trigger mRNA decay (Rana, 2007). 
The involvement of miRNAs in the control of ESC potential is demonstrated 
by the study of DGCR8 and Dicer mutant mice. DGCR8 knockout (KO) 
ESCs have an extended population doubling time compared to their wild-type 
and heterozygous counterparts, but are morphologically normal and continue 
to express ESC specific markers. They accumulate in the G1 phase of the cell 
cycle, indicating that DGCR8 is required for normal ESC proliferation and 
cell-cycle progression. Moreover DGCR8 KO ESCs cannot efficiently silence 
the ESC program, even under stringent differentiation conditions (Wang, et 
al., 2007). The role of miRNAs in ESCs is supported also by Bernstein work, 
in which he found that Dicer absence leads to embryonic lethality. Dicer KO 
pre-gastrulation embryos showed lack of Oct4-positive epiblast cells and 
could not undergo gastrulation. As expected, mESCs could not be derived 
from Dicer mutant embryos (Bernstein, et al., 2003). In 2005, Kanellopoulou 
and co-workers were able to generate Dicer-deficient ESCs using a 
conditional gene targeting approach. Surprisingly, these mutant ESCs are 
viable, hold an appropriate morphology, and express normal levels of 
pluripotency markers (Kanellopoulou, et al., 2005). But, consistent with in 
vivo finding (Bernstein, et al., 2003), Dicer-deficient ESCs failed to 
differentiate in multiple assays.  
These works highlight the relevance of miRNA function in determining ESC 
fate.  
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Figure 8. The miRNA processing pathway 
This miRNA maturation includes the production of the primary miRNA transcript (pri-
miRNA) by RNA polymerase II or III and cleavage of the pri-miRNA by the 
microprocessor complex Drosha–DGCR8 (Pasha) in the nucleus. The resulting precursor 
hairpin, the pre-miRNA, is exported from the nucleus by Exportin-5–Ran-GTP. In the 
cytoplasm, the RNase Dicer in complex with the double-stranded RNA-binding protein 
TRBP cleaves the pre-miRNA hairpin to its mature length. The functional strand of the 
mature miRNA is loaded together with Argonaute (Ago2) proteins into the RNA-induced 
silencing complex (RISC), where it guides RISC to silence target mRNAs through mRNA 
cleavage, translational repression or deadenylation, whereas the passenger strand (black) is 
degraded (Winter, et al., 2009). 
 
4.1 miRNAs in ESC function 
ESCs express a specific set of miRNAs in undifferentiated and differentiated 
conditions as found by cloning and sequencing of small RNAs (Houbaviy, et 
al., 2003). Among miRNAs expressed in ESCs, there is highly represented the 
family of miRNAs with the AAGUGC seed sequence. Members of this family 
are organized in two major clusters. The conserved miR-302/367 cluster 
comprises four miRNAs (miR-302a, miR-302b, miR-302c and miR-302d) 
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and the unrelated miR-367. The second cluster is less conserved. In the mouse 
it is commonly referred to as the miR-290-295 cluster and includes six 
miRNAs (miR-290, miR-291a, miR-291b, miR-292, miR-294 and miR-295) 
and miR-293 (Rosa, et al., 2013). Further studies demonstrated that miR290 
cluster regulates retinoblastoma like-2 (Rbl2) at the post-transcriptional level, 
leading to a transcriptional repression of Dnmt3a and Dnmt3b and the 
appearance of DNA-methylation defects, resembling those observed in Dicer 
KO cells (Benetti, et al., 2008).  
Other miRNAs have been involved in ESC differentiation, as miR-134, miR-
296, and miR-470, which target and down-regulate the core transcription 
factors Nanog, Oct4, and Sox2 (Tay, et al., 2008). Similarly, miR-200c, miR-
203, and miR-183 repress Sox2 and Klf4 (Wellner, et al., 2009). It’s 
interesting that the same transcription factors can in turn regulate the 
expression of specific miRNAs. Indeed, genome-wide mapping of binding 
sites for key ESC transcription factors revealed highly overlapping occupancy 
of Oct4, Sox2, Nanog and Tcf3 at the transcriptional start sites of miRNA 
transcripts, preferentially or uniquely expressed in ES cells (Marson, et al., 
2008).   
Among other miRNAs playing a role in ESC differentiation, there is the let-7 
family. In mammals it includes several let-7 species (let-7a to let-7i) and other 
miRNAs, such as miR-98 and miR-202 [101]. Members of the let-7 family 
accumulate during development and differentiation, with a parallel reduction 
of their targets, and have a role in cancer (Büssing, et al., 2008). In ESCs, 
levels of let-7 miRNAs are regulated at the post-transcriptional level. The 
RNA binding protein Lin28 associate to the terminal loop of let-7 precursors 
blocking the production of the mature miRNA and targeting it for degradation 
(Hagan, et al., 2009) (Piskounova, et al., 2011). Coherently with its function, 
Lin28 is highly expressed in undifferentiated ESCs and is reduced during 
differentiation, when levels of mature let-7 increase. This mechanism is 
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regulated by a feedback loop, in which let-7 negatively regulates Lin28 
(Rybak, et al., 2008). 
Our laboratory also contributed to the characterization of other miRNAs 
working in the control of ESC differentiation. In particular, Tarantino and co-
workers identified miRNAs differentially expressed in different steps of ESC 
differentiation. They clustered miRNAs in three groups on the basis of their 
expression profile: 1) miRNAs expressed in undifferentiated ESCs and that 
decreased during differentiation; 2) miRNAs already present in ESCs and 
increased in differentiating cells; 3) miRNAs completely undetectable in 
undifferentiated cells and increased on induction of differentiation. Focusing 
their study on a small group of miRNAs whose candidate targets are down-
regulated on ESC differentiation, the group demonstrated that miR-34a, miR-
100, and miR-137 are required for proper differentiation of mouse ESCs, and 
they function in part by targeting Sirt1, Smarca5, and Jarid1b mRNAs 
(Tarantino, et al., 2010). 
These are only few examples of miRNA involved in ESCs. But a lot has still 
to be done, not only to identify novel miRNAs but also, and especially, to 
understand their contribution in governing ESC fate. 
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Methods 
 
Reporter plasmid generation 
The 3’ untranslated region (UTR) of Dies1 (from nucleotide 2260 to 3268) 
was obtained by polymerase chain reaction (PCR) from ESC genomic DNA 
and cloned in pCAG-luc vector (Tarantino, et al., 2010) downstream of the 
firefly luciferase gene. The mutated 3’ UTR of Dies1 carrying a scrambled 
seed sequence of miRNAs was obtained through a double round of PCR to 
insert the mutation. This fragment was cloned downstream of the firefly 
luciferase gene in EcoRI site in pCAG-luc vector.  
For FRET analysis, EGFP was derived from pEGFP-N1 (Clontech, Mountain 
View, CA, USA) and then cloned downstream of Dies1 in pCAG vector by 
HindIII and NotI restriction. Alk3 cDNA was derived from pSport vector 
(U.S. National Institutes of Health Mammalian Gene Collection, Bethesda, 
MD, USA) by PCR and cloned in pCAG vector in BamHI and HindIII 
restriction sites. mCherry was derived from pmCherry vector (Clontech) by 
PCR and cloned downstream of Alk3 by HindIII and NotI restriction. p75-
mCherry vector was kindly provided by Dr. Simona Paladino 
(Universita`Federico II, Naples, Italy). The oligonucleotides used for cloning 
are reported in Appendix 1.  
 
Cell culture, transfection and treatment 
E14Tg2a (BayGenomics) mouse ESCs were maintained on feeder-free, 
gelatin-coated plates in the following medium: Glasgow Minimum Essential 
Medium (GMEM, Sigma) supplemented with 2 mM glutamine (Invitrogen), 
100 U/ml penicillin/streptomycin (Invitrogen), 1mM sodium pyruvate 
(Invitrogen), 1X nonessential aminoacids (Invitrogen), 0.1 mM β-
mercaptoethanol (Sigma), 10% FBS (Hyclone), and 10
3
 U/ml leukemia 
inhibitory factor (LIF, Millipore).  
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C2C12 myoblasts were maintained in Dulbecco’s Modified Eagle Medium 
supplemented with 2 mM glutamine (Invitrogen), 100 U/ml 
penicillin/streptomycin (Invitrogen), 10% FBS (GIBCO). 
The cell lines were plated at 6x10
4
 cells/cm
2
 16 h before transfection. 
Transfection of plasmids, pre-miRs, and anti-miRs (both from Ambion) in 
ESCs were performed using Lipofectamine 2000 (Invitrogen) following 
manufacturer’s instructions. Short hairpin RNAs (shRNAs) in the pLKO.1-
puro vector (Thermo Scientific) were used for suppressing Dies1 in ESCs. 
Transduced cells were selected with 2 µg/ml of puromycin (Sigma). 
For cell treatment, ESCs and C2C12 were grown over night in knockout 
serum replacement (KSR) containing medium with LIF or DMEM plus 1% 
FBS, respectively, and then treated for the indicated time with 20 ng/ml of 
BMP4 (R & D Systems) and 20 ng/ml of activin (R&D). 
 
ESC and C2C12 differentiation 
Neural differentiation by monolayer (Parisi, et al., 2010) was induced plating 
ESCs onto gelatine-coated dishes at low density (3x10
3
 cells/cm
2
) in the 
following differentiation medium: GMEM supplemented with 10% knockout 
serum replacement (KSR, Invitrogen), 0.1mM β-mercaptoethanol, 2mM 
glutamine, 100 U/ml penicillin/streptomycin. Differentiation medium was 
changed on alternate days. 
For serum free embryo body (SFEB) differentiation, 1x10
6
 ESCs were plated 
in 100-mm Petri dishes to allow spontaneous aggregation into SFEBs for at 
least 4 days, in the following differentiation medium: GMEM supplemented 
with 10% knockout serum replacement (KSR, Invitrogen), 0.1mM β-
mercaptoethanol, 2mM glutamine, 100 U/ml penicillin/streptomycin 
(Watanabe, et al., 2005). Dorsomorphin (2 µM; Sigma) was added once in the 
differentiation medium when the cells were plated in Petri dishes to induce 
SFEB formation. DMSO was used as negative control. 
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For differentiating C2C12 myoblasts to myotubes, 20x10
3
cells/cm
2
 were 
plated and, the following day, were transferred in a differentiation medium 
containing Dulbecco’s Modified Eagle Medium with 2 mM glutamine 
(Invitrogen) and 2% horse serum (Sigma), for 3 days. 
 
Luciferase reporter assay 
For luciferase assay, ESCs were plated at 3x104 cells/cm2 16 hours before 
transfection in 24-well. Plasmids carrying the wild type or mutated Dies1 
3’UTR, pre-miR-125a and 125b were co-transfected in ESCs by using 
Lipofectamine 2000 (Invitrogen). pRL-TK vector (Promega) expressing 
Renilla luciferase was co-transfected as an internal control. After 24 hours 
from transfection, the cells were lysed with 200µl of 1X Passive Lysis Buffer. 
Firefly and Renilla luciferase activities were measured with the dual-
luciferase reporter system (Promega) by Sirius Luminometer (Berthold 
Detection Sistems). The data were expressed as relative to control transfected 
cells after normalization to Renilla luciferase reading. All transfection 
experiments were repeated in triplicate. 
 
Alkaline phosphatase staining 
For alkaline phosphatase staining, ESCs were cultured at clonal density (20-
50 cells/cm
2
). The cells were fixed in 10% cold Neutral Formalin Buffer 
(10% formalin, 110 mM Na2HPO4, 30mM NaH2PO4.H2O) for 15 minutes 
and then rinsed in distilled water for 15 minutes. The staining was obtained by 
incubation for 45 minutes at room temperature with the following staining 
solution: 0,1M Tris-HCl, 0,01% Naphthol AS MX-PO4 (Sigma), 0,4% N,N-
Dimethylformamide (Sigma), 0,06% Red Violet LB salt (Sigma). 
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BrdU assay 
For BrdU incorporation and detection, subconfluent ESCs were incubated in 
ESC medium containing BrdU for 2 hours and then the cells were fixed and 
processed for immunofluorescence with BrdU labelling and detection kit 
(Roche) following manufacturer’s instruction. Fluorescence microscopy was 
performed as described in Immunostaining section. 
 
RNA isolation, Real-Time PCR and TaqMan analysis 
Total RNA from undifferentiated and differentiated ESCs and C2C12 was 
extracted by using TRI-Reagent (Sigma). The first-strand cDNA was 
synthesized according to the manufacturer’s instructions (M-MLV RT, New 
England BioLabs). Real-time RT-PCR was carried out on an ABI PRISM 
7900HT Sequence Detection System (Applied Biosystems) using Power 
SYBR Green PCR Master mix (Applied Biosystems). The housekeeping 
GAPDH mRNA was used to normalize the samples using 2
-∆Ct
 method. Gene 
specific primers used for amplification are listed in Appendix 2.  
For TaqMan analysis, total RNA was isolated from undifferentiated and 
differentiated ESCs and C2C12with mirVana microRNA Isolation kit 
(Ambion) according to the manufacturer’s instructions. From each sample, 10 
ng of total RNA were used to synthesize single-stranded cDNA with TaqMan 
MicroRNA reverse transcription kit (Applied Biosystems) combined with the 
specific primer for miR-125a, miR-125b, miR-let7e, miR99b, or U6 as 
internal control. Expression level of miRNAs were measured by using 
TaqMan MicroRNA detection kit (Applied Biosystems) with the 7500 Real 
Time PCR System instrument and the Sequence Detection Systems (SDS) 
software version 1.4 (Applied Biosystems).  
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Protein extraction and western blot analysis  
For  protein extracts, cells were lysed in a buffer containing 20 mM Tris-HCl 
(pH 7,5) 150 mM NaCl, 1 mM EDTA, 1% Triton,  1% sodium deoxycholate 
and protease inhibitor cocktail (Sigma). The lysates were cleared by 
microcentrifugation at 14,000 rpm and then mixed with Laemli buffer. 
Proteins were resolved on SDS-PAGE, transferred onto PVDF membrane 
(Millipore) and incubated with indicated antibodies according to the 
manufacturer’s recommendations. The following primary antibody were used: 
anti-Dies1 (Aloia, et al., 2010); anti-phospho-Smad1,5,8 (1:1000; Cell 
Signalling); anti-Smad1 (1:1000, Cell Signalling); anti-Lin28 (1:700, 
Abcam); anti-phospho-Erk1 (1:1000, Cell Signalling); anti-Erk1 (1:1000, 
Santa Cruz); anti-GAPDH (1:1000, Santa Cruz). 
 
Chromatin immunoprecipitation (ChIP)-qPCR analysis 
ESCs, transfected with pre-miRs or treated with BMP4 as indicated, were 
cross-linked with 1% formaldehyde for 10 minutes at room temperature and 
formaldehyde was then inactivated by the addition of 125 mM glycine. The 
chromatin was sonicated to an average DNA fragment length of 500-1000 bp. 
To immunoprecipitate soluble chromatin extracts were used anti-H3K4-3me 
(Millipore, Billerica, MA, USA), anti-H3K27-3me (Millipore) antibodies, 
anti-Smad1 (Cell Signalling) antibodies. Appropriate IgGs were used as 
negative control. Supernatant obtained without antibody was used as input 
control. The amount of precipitated DNA was calculated by real-time PCR 
relative to the total input chromatin, and expressed as percentage of total 
chromatin according to the following formula: 2
ΔCt
, where Ct represents the 
cycle threshold and ΔCt = Ct(input) – Ct(immunoprecipitation). 
Oligonucleotide pairs are listed in Appendix 3.  
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Immunostaining and microscopy 
For immunostaining, monolayer differentiated ESCs were fixed in 4% 
paraformaldehyde and permeabilized with 0.2% Triton X-100 in 10% FBS 
(Invitrogen)/1% BSA in PBS for 15’ at room temperature. Thus the samples 
were incubated with the primary  anti- bIII-tubulin 1:400 (Sigma–Aldrich) for 
2 h at room temperature. Following primary antibodies incubation, the cells 
were incubated with appropriate secondary antibody (1:400, Alexa Molecular 
Probes) and counterstained with DAPI (Calbiochem). Images were captured 
with an inverted microscope (DMI4000, Leica Microsystems) (Parisi et al., 
2010).  
SFEBs were collected at day 4 of differentiation and fixed in 4% 
paraformaldehyde. After dehydration with increasing percentage of EtOH, 
samples were embedded in paraffin, sectioned in 7μm slices and mounted on 
glass slides. After rehydration and permeabilization with 0.2% TX-100, 
unmasking was performed in Citrate Buffer 1x. The non-specific block was 
performed by treating in 10% FBS/1% BSA/0.1% Tween 20/ 1x PBS for 2-3h 
at RT followed by primary antibodies incubation. Nuclei were counterstained 
with Dapi (Calbiochem). The following primary antibodies were used: anti-
Oct3/4 (1:200, Santa Cruz), anti-Nanog (1:500, Calbiochem), anti-Sox1 
(1:100, Santa Cruz). The appropriate secondary antibodies were used (1:400, 
Alexa Molecular Probes). Confocal microscopy was performed with an LSM 
510 Meta microscope (Zeiss) using LSM 510 Meta software and LSM Image 
Browser (Zeiss).  
 
Teratoma formation 
ESCs transfected with pre-miR-125b or pre-miR-ctrl were differentiated as 
SFEBs for 3 days. Then SFEBs were dissociated and 2x10
6 
cells were used 
for subcutaneous injection in nude mice. Four weeks after the injection, 
tumors were surgically dissected from the mice. Samples were fixed in 4% 
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paraformaldehyde and embedded in paraffin. Sections were stained with 
hematoxylin and eosin. 
 
Derivation of epiblast stem cells (epiSCs) from SFEBs and cell culture 
For derivation of EpiSCs, SFEBS at 4 and 5 days of differentiation were 
dissociated into a single-cell suspension with 0.05% Trypsin-EDTA at 37°C 
for 5 min. Individual cells were then seeded in 12-well plates coated with FBS 
at a density of 12,000 cells/well in epiSC medium as follows: 1 volume of 
DMEM/F12 combined with 1 volume of Neurobasal medium, supplemented 
with 0.5% N2 supplement, 1% B27 supplement, 2 mM glutamine 
(Invitrogen), 20 ng/ml Activin A (R&D Systems), and 12 ng/ml bFGF 
(Invitrogen). SB-431542 (10 µM; Sigma) was added once in the 
differentiation medium when the cells were plated to induce SFEB formation. 
DMSO was used as negative control. The medium was changed on alternate 
days. 
 
Fluorescence resonance energy transfer (FRET)-fluorescence lifetime 
imaging microscopy (FLIM) experiments 
For FRET analysis, ESCs were transfected with Dies1-GFP (donor) 
expression vector alone or in combination with Alk3-mCherry or p75-
mCherry expressing vectors (acceptors. After 24 h from transfection, the cells 
were fixed in 4% paraformaldehyde and analyzed for FRET in PBS1X. FRET 
measurements were performed by using a Leica TCS SMD FLIM confocal 
microscope (Leica Microsystems). For each field, the lifetime (τ) was 
calculated with LAS AF software (Leica Microsystems), taking into account 
the instrument response function (IRF). The data were expressed as 
percentage of FRET efficiency (E), which was derived using the following 
equation: 
E = 1 - (τFRET /τ) x 100 
39 
 
where τFRET is the lifetime of the donor population that is interacting with the 
acceptor, and τ is the lifetime of non-interacting donor population (Llères, et 
al., 2007). The images representing the lifetime on the basis of a colour scale 
were obtained with Symphotime software (PicoQuant GmbH, Berlin, 
Germany) and brightness and contrast were adjusted in Photoshop CS2. 
 
Statistics  
Data are presented as the means ± SD of at least three independent 
experiments. Whenever necessary, statistical significance of the data was 
analyzed using Student’s t test. 
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Results 
1. Dies1 is a direct target of miR-125a and miR-125b in mouse ESCs 
Dies1 was demonstrated to have a role in ESC differentiation, indeed its 
suppression impairs the differentiation program (Aloia et al., 2010). We 
decided to investigate whether a physiological modulation of Dies1 
expression could be one of the mechanisms controlling ESC differentiation. 
To this aim, we searched for miRNAs targeting Dies1 3’UTR by using 
bioinformatic tools such as TargetScan and Miranda. Among the predicted 
miRNAs targeting Dies1, we choose to study miR-125a and miR-125b based 
on their conservation and identity in the seed sequence (Figure 9). These 
miRNAs belong to the same family and have an high homology in their 
sequence. They are encoded by two different genes: miR-125a gene is 
localized on mouse chromosome 17 clustered with miR-99b and Let-7e; miR-
125b is encoded by two genes on chromosome 9 (miR-125b-1) and on 
chromosome 16 (miR-125b-2).  
To check whether they could target Dies1 3’UTR, we overexpressed their 
precursors in undifferentiated ESCs and we analyzed Dies1 protein level by 
western blot assay. We found that Dies1 protein is strongly reduced in ESC 
overexpressing pre-miR-125a and pre-miR-125b, alone or in combination 
(pre-miR-mix). On the contrary, the suppression of miRNAs by anti-miR-
125a and/or anti-miR-125b leads to an accumulation of Dies1 protein, 
supporting the hypothesis that these two miRNAs could regulate Dies1 
expression (Figure 10). To confirm that this regulation occurs directly, we 
have performed a luciferase assay experiment. We have transfected ESCs 
with the specific pre-miR and with a construct encoding the luciferase gene 
fused to Dies1 3’UTR. As control, we have generated a construct carrying a 
form of Dies1 3’UTR mutated in the sequence recognized by the miRNAs. As 
you can see in the Figure 11, the expression of miR-125a and miR-125b 
reduced the luciferase activity of the construct carrying the Dies1 wt 3’UTR, 
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while with that carrying the mutated 3’UTR the luciferase activity was not 
affected. This result clearly demonstrates that the miRNAs 125a and 125b 
regulate Dies1 expression by binding directly its 3’UTR.  
 
 
 
 
 
Figure 9. Predicted target site of miR-125a and miR-125b in the 3’ UTR of Dies1.  
miR-125a and miR-125b have the same seed region (in bold) and high sequence 
homology. They target the Dies1 3’UTR. 
 
 
 
 
 
 
Figure 10. Dies1 protein level on miRNA modulation. 
ESCs were transfected with the indicated pre-miR or anti-miR, alone or in combination 
(pre or anti miR-mix). 24h after transfection Dies1 protein levels were evaluated by 
western blot analysis. 
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Figure 11. miR-125a and miR-125b directly regulate Dies1 expression by targeting its 
3’ UTR.  
ESCs were co-transfected with the indicated pre-miR and the reporter bearing wild-type 
(wt) or mutated (mut) Dies1 3’ UTR. Luciferase activity was measured 24h after 
transfection and normalized with Renilla luciferase activity. **P < 0.01. 
 
 
2. miR-125a impairs ESC differentiation 
miR-125a is expressed in undifferentiated ESCs and its expression level stays 
almost constant up to four days of differentiation. Then it reaches high levels 
in terminally differentiated cells (Figure 12). Since Dies1 is involved in ESC 
fate and it’s regulated by miR-125a at post-transcriptional level, we have 
decided to further investigate the role of miR-125a in ESCs. To this aim, we 
have overexpressed miR-125a in ESCs and cultured them in subconfluent 
condition in the proper medium, supplemented or not with LIF. After 7 days 
of culture, we have analyzed the maintenance of stemness phenotype 
performing an Alkaline Phosphatase (AP) staining. We didn’t observed 
difference in the number of colonies positive for AP staining upon miR-125a 
overexpression in undifferentiated condition (Figure 13). Moreover, we 
evaluated the expression level of stemness genes as Oct3/4, Nanog and Rex1 
by Q-PCR, but we didn’t find difference between the ESCs overexpressing 
miR-125a and the control (Figure 14). However, when we removed LIF from 
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the culture medium, allowing ESCs to spontaneously differentiate, mir-125a 
ectopic expression induced an increase of colonies stained with alkaline 
phosphatase suggesting an impairment of differentiation(Figure 13). 
 
 
Figure 12. Expression profile of miR-125a during ESC neuronal differentiation. 
miR-125a levels were measured by Taqman assay in undifferentiated ESCs and during 
different time points of neuronal differentiation.U6 RNA level is used to normalize. 
 
 
Figure 13. miR-125a maintains stemness in LIF removal induced differentiation. 
ESCs overexpressing miR-125a or miR-ctrl were grown for 7 days in culture medium 
supplemented or not with LIF. The histogram reports the number of AP negative (grey) 
and positive colonies (white). In absence of the cytokine, miR-125a overexpressing cells 
have an higher number of stemness colonies (AP positive). 
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Figure 14. miR-125a expression doesn’t affect stemness. 
Analysis of the expression level of stemness markers (Oct3/4, Nanog, Rex1) in ESCs 
overexpressing miR-125a or miR-ctrl. The data are represented as fold change relative to 
the control. 
 
To further analyze this phenotype, we grew the cells transfected with the 
control pre-miR or the pre-miR-125a as monolayer in chemically defined 
medium. At day 7, the immunostaining assay showed that the control cells 
differentiated mainly as neuroectoderm expressing the β-III tubulin marker 
and losing the stemness markers Oct3/4 and Nanog. The presence of miR-
125a increases the number of the cells positive for stemness markers, 
reducing those of neuroectodermal origin (Figure 15A). We have also 
quantified the different expression of stemness (Oct3/4, Nanog, Sox2) and 
neuroectodermal (Map2) markers by Q-PCR analysis of pre-miR transfected 
ESC at 7 days of differentiation (Figure 15B).  
To better define the identity of the single cell in the first steps of ESC 
differentiation, we decided to use a differentiation system based on the 
formation of serum free embryo bodies (SFEBs). We transfected pre-miR-
125a or pre-miR-ctrl in ESCs and differentiated them as SFEBs. At four days 
of differentiation, we have analyzed the phenotype by immunofluorescence 
experiment. Almost all the control transfected cells expressed the 
neuroectodermal marker Sox1 and only few cells still expressed the stemness 
markers Oct3/4 and Nanog. Following miR-125a overexpression, the 
phenotype dramatically changed: a lot of cells maintain the expression of 
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Oct3/4 and Nanog and few cells are Sox1 positive (Figure 16A). The same 
result was confirmed by Q-PCR analysis of mRNA level of stemness (Oct3/4, 
Nanog, Sox2) and neuroectodermal (Pax6, Sox1) markers, indicating that 
miR-125a impairs ESC differentiation maintaining the expression of stemness 
factors (Figure 16B). This phenotype is very similar to that observed upon 
Dies1 suppression in ESCs, in agreement with the finding that miR-125a 
controls Dies1 expression (Figure 17). 
 
 
 
Figure 15. miR-125a overexpression impairs ESC neuronal differentiation. 
ESCs were transfected with the indicated pre-miR and induced to differentiate in 
monolayer. After 7 days of differentiation, stemness (Oct3/4, Nanog, and Sox2) and 
neuronal markers (βIII-tubulin, Map2) were analyzed by immunostaining (A) and by qPCR 
analysis (B). Scale bars = 100 µm. The data in B are expressed as fold change relative to 
the control. * P < 0.05, ** P < 0.01. 
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Figure 16. miR-125a maintains the expression of stemness markers during SFEB 
differentiation. 
Following miR-125a overexpression, ESCs were differentiated for 4 days as SFEBs. The 
immunostaining analysis (A) shows an increased number of cells expressing stemness 
markers (Nanog, Oct3/4) and a reduced number of those positive for neuroectodermal 
marker (Sox1), in miR-125a transfected cells compared to the control . Scale bars = 20 µm. 
The percentage of positive cells on total cells for each marker was counted in ≥ 10 
independent fields and was represented in the histogram. The same phenotype was 
confirmed by the qPCR analysis (B) of mRNA level of stemness (Oct3/4, Nanog, Sox2) 
and neuronal (Pax6, Sox1) markers. Data are expressed as fold change relative to the 
control. * P < 0.05, ** P < 0.01. 
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Figure 17. Dies1 suppression induces an impairment of SFEB differentiation, 
maintaining the expression of stemness markers. 
ESCs were transfected with shRNA against Dies1 (sh Dies1) or a negative control (sh ctrl) 
and subjected to SFEB differentiation. After 4 days of differentiation, the expression of 
stemness (Nanog) and neuroectodermal (Sox1) markers was evaluated by immunostaining 
analysis. Scale bars = 20 µm. 
 
 
Moreover, it is known that stemness genes have an epigenetic signature 
associated to their expression level. In particular they are characterized by 
high levels of histone H3 lysine 4 methylation (H3K4-3me) and low levels of 
histone H3 lysine 27 methylation (H3K27-3me), indicating an active 
transcription of these genes (Azuara, et al., 2006). Given the maintenance of 
stemness gene expression following miR-125a overexpression, we decided to 
check whether, at day 4 of SFEB differentiation, stemness genes lost the 
epigenetic signature typical of undifferentiated condition. To test this 
hypothesis, after 4 days of SFEB differentiation we immunoprecipitated the 
chromatin of ESCs overexpressing miR-125a and those transfected with the 
control, using antibodies able to recognize the marks H3K4-3me and H3K27-
3me. Then the chromatin was amplified with specific primers for the region 
surrounding the transcriptional start site of stemness genes. We confirmed 
that miR-125a overexpressing cells retain high level of H3K4-3me and low 
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level of H3K27-3me at day 4 of differentiation, maintaining the 
characteristics of undifferentiated ESCs (Figure 18). 
We wondered that the block of differentiation observed upon miR-125a 
overexpression could be associated to an alteration of cell proliferation. To 
exclude this possibility, we performed a BrdU incorporation assay in ESCs 
overexpressing miR-125a or a control miR. But, at 2h from the BrdU 
incorporation, no significant changes in the proliferation rate were observed 
(Figure 19). 
 
 
 
 
 
Figure 18. miR-125a ectopic expression alters the methylation state of histone H3 
during SFEB differentiation. 
ESCs transfected with the indicated pre-miR were induced to differentiate through SFEB 
formation. At day 4 of differentiation, the cells were subjected to chromatin 
immunoprecipitation with antibodies against H3K4-3me and H3K27-3me. 
Immunoprecipitated DNA was amplified by qPCR with primers designed on the 
transcriptional start sites of the indicated genes. Data are expressed as fold enrichment 
relative to the control. * P < 0.05. 
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Figure 19. miR-125a overexpression doesn’t affect cell proliferation. 
ESCs were transfected with the indicated pre-miR. 24h after the transfection, BrdU was 
incorporated for 2h. Immunostaining with a specific antibody reveals the amount of BrdU 
incorporation. Histogram indicates the percentage of BrdU positive cells relative to the 
total cells. 
 
 
3. The phenotype of miR-125a ectopic expression is dependent on Dies1 
We found that miR-125a overexpression gives an impairment of ESC 
differentiation, resembling the phenotype of Dies1 suppression during 
differentiation. To explore whether the phenotype of miR-125a expression 
could be due to Dies1 downregulation, we performed a rescue experiment co-
transfecting ESCs with pre-miR-125a or pre-miR-ctrl and a construct 
encoding Dies1 lacking its 3’UTR and thus insensitive to miRNA regulation. 
The cells were then differentiated as SFEBs for 4 days and the phenotype was 
analyzed by immunostaining and Q-PCR. We found that the number of the 
cells positive for Sox1 or Oct3/4 and Nanog is very similar to the control 
cells, when they are co-transfected with Dies1 and miR-125a (Figure 20). 
Thus, restoring Dies1 level in cells overexpressing miR-125a, the expression 
level of stemness and differentiation markers is re-established. 
Aloia et al. previously demonstrated that Dies1 suppression in ESCs gives a 
reduction of BMP4 target genes, Id1 and Id3. The same effect was observed 
upon miR-125a overexpression and it was due to Dies1: indeed, co-
transfection of Dies1 and miR-125a rescued the expression of Id genes 
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(Figure 21). These data demonstrated that the effects of miR-125a 
overexpression in ESCs are, above all, mediated by Dies1. 
 
Figure 20. Dies1 re-expression rescues the phenotype induced by miR-125a 
overexpression. 
ESCs were co-transfected with the indicated pre-miR and a construct encoding Dies1 
lacking its 3’UTR (Dies1) or the empty vector (mock), and differentiated for 4 days as 
SFEBs. The expression of stemness (Oct 3/4 , Nanog) and neuroectodermal (Sox1) 
markers was analyzed by immunostaining. Scale bars = 20 µm. The percentage of positive 
cells on total cells for each marker was counted in ≥ 10 independent fields and reported in 
the histogram (A). The same samples were collected for qPCR analysis of stemness (Oct 
3/4 , Nanog) and differentiation (Sox1, Pax6) markers (B). * P < 0.05. 
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Figure 21. The reduction of BMP4 signalling upon miR-125a overexpression is due to 
Dies1 suppression. 
The analysis of BMP4 target gene expression (Id1, Id3) by qPCR was performed on ESCs 
co-transfected with the indicated pre-miR and a vector expressing Dies1 lacking its 3’UTR 
(Dies1) or an empty vector (mock), at day 4 of SFEB differentiation. * P < 0.05. 
 
 
4. BMP4 controls miR-125a and, in turn, Dies1 
Dies1 has an important role in BMP4 pathway, acting as AlK3 co-receptor. 
To support this finding, we performed a FRET experiment, using the 
multiphoton FLIM technique. We transfected in ESCs a construct carrying 
Dies1 fused to EGFP (donor) and another carrying Alk3 fused to mCherry 
fluorescent protein (acceptor). In these cells we observed 6% of FRET 
efficiency, indicating that Dies1 and Alk3 were interacting at molecular level 
(Figure 22). As negative control, we used ESCs transfected with Dies1-EGFP 
fusion protein and the unrelated receptor p75-Cherry; in this condition we 
didn’t find any significant molecular interaction. This result highlights the 
role of Dies1 in the Alk3 receptor complex, being necessary for BMP4 
signalling.  
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Figure 22. Dies1 and Alk3 interact at molecular level. 
ESCs were transfected with a vector expressing Dies1 fused to EGFP (donor) alone or 
together with a vector expressing Alk3 fused to mCherry fluorescent protein (acceptor). 
ESCs co-transfected with Dies1-GFP and the p75 receptor fused to mCherry were used as 
negative control. Energy transfer was measured after 24 h. Colour of the images represents 
the time required for the energy transfer (lifetime) as indicated in the colour bar, where the 
values represent lifetime (ns). The more blue the colour, the closer are the donor and the 
acceptor. Histogram represents the efficiency of energy transfer (%) normalized to the 
control. **P < 0.01. 
 
Moreover, we know that Dies1 expression is controlled at post-transcriptional 
level by miR-125a. So, we wondered whether the physiological level of miR-
125a could be modulated by BMP4 itself. To verify this possibility, we 
treated ESCs with BMP4. First of all we controlled that BMP4 was working, 
analyzing the induction of BMP4 target genes (Id1 and Id3) and the 
phosphorylation status of Smad1,5,8 (Figure 23). Once assessed that BMP4 
was correctly signalling, we analyzed the level of precursor and mature miR-
125a, at 1h and 24h after the treatment respectively. The pri-miR-125a is 
highly increased after 1h of BMP4 treatment, as indicated by the Q-PCR 
performed with two oligonucleotide pairs annealing in two different region of 
precursor miR-125a (Figure 24A). The Taqman assay showed that this 
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increase is associated to an accumulation of the mature form of miR-125a 24h 
after the BMP4 stimulation (Figure 24B). To prove that miR-125a increase 
depends on BMP4 activation, we downregulated the BMP4 receptor Alk3 by 
siRNA, decreasing the activity of BMP4 pathway (Figure 25). We confirmed 
that miR-125a accumulates in Alk3 silenced ESCs compared to control ESCs, 
24h after the transfection (Figure 26). Since this miRNA targets Dies1, we 
speculated that 24h following BMP4 induction, when the miR-125a level is 
increased, Dies1 protein should be decreased. For this reason we evaluated 
Dies1 protein level by western blot analysis and we found that it was reduced 
at 24h from the treatment (Figure 27A). Moreover its mRNA level didn’t 
change at this time point, supporting the finding that miR-125a regulate Dies1 
at post-transcriptional level (Figure 27B). These data indicate that BMP4 
controls miR-125a level which in turn modulate Dies1 expression, regulating 
BMP4 signalling.  
 
 
 
 
Figure 23. Activation of the BMP4 signalling. 
ESCs were cultured overnight in chemically defined medium (KSR) and LIF. Then, the 
cells were treated with BMP4 for 1h. The activation of the pathway was checked by qPCR 
analysis of BMP4 target gene expression (Id1, Id3) and by western blot analysis of the 
phosphorylation status of Smad1,5,8. Data are expressed as fold change relative to the 
control. * P < 0.05, ** P < 0.01. 
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Figure 24. BMP4 affect the expression of miR-125a. 
ESCs were cultured overnight in chemically defined medium (KSR) plus LIF and then 
treated with BMP4 for 1h and 24h. The level of pri-miR-125a was measured by qPCR 1h 
after the treatment (A). Primers used amplify the regions upstream (up) and downstream 
(dw) the sequence of the mature miR-125a. The analysis of mature miR levels was done at 
24h from the BMP4 stimulation by TaqMan analysis (B). Data are expressed as fold 
change relative to control. ** P < 0.01. 
 
 
 
 
 
Figure 25. Alk3 suppression downregulates BMP4 signalling. 
ESCs were transfected with a siRNA against Alk3 or a control siRNA. 24h after 
transfection, the expression level of Alk3 and BMP target genes (Id1, Id3) was measured 
by qPCR analysis. Data are expressed as fold change relative to control. * P < 0.05. 
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Figure 26. Alk3 suppression reduces the expression of miR-125a. 
ESCs were transfected with a siRNA against Alk3 or a control siRNA. After 24 h from 
transfection, the level of mature miR was measured by TaqMan analysis. * P < 0.05. 
 
 
Figure 27. BMP4 stimulation modulates Dies1 expression at post-transcriptional 
level. 
Dies1 protein level was measured by Western blot in ESCs treated with BMP4 for 24 h by 
using a specific antibody for Dies1 (A). Gapdh was used as loading control. The same 
samples were subjected to qPCR analysis of Dies1 transcript level (B). Data are expressed 
as fold change relative to control. 
 
 
To verify that BMP4 regulates miR-125a directly, we immunoprecipitated the 
chromatin of ESCs treated or not with BMP4 for 1h, using an antibody 
against Smad1, the effector of BMP4 signalling. We analyzed, by Q-PCR, the 
immunoprecipitated chromatin with 10 primers designed to cover the region 
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upstream the miR-125a gene. Figure 28 shows that the regions 7 and 8 are 
strongly enriched after BMP4 treatment, indicating that they are possible 
binding regions for Smad1. It’s interesting to note that these regions contain 
predicted binding sites for Smad1. These findings demonstrate that in ESCs 
BMP4 regulates directly miR-125a expression, recruiting Smad1 to the proper 
binding site on the miR-125a gene. This, in turn, controls Dies1 level 
modulating BMP4 signalling, generating a negative feedback loop.  
Since miR-125a gene is in cluster with miR-99b and let-7e, we wondered 
whether BMP4 could control the expression of these miRNAs too. After 24h 
of BMP4 treatment, we observed different effects in the level of mature 
miRNA: let-7e was unaffected, while miR-99b increased (Figure 29). Given 
the regulation of miR-99b similar to that of miR-125a, we decided to analyze 
the role of miR-99b in ESC differentiation. But, at day 4 of SFEB 
differentiation, the expression of stemness markers was very similar between 
ESCs overexpressing miR-99b and the control cells, indicating that it hasn’t a 
specific role in this context (Figure 30). 
 
 
Figure 28. Upon BMP4 treatment Smad1 is recruited to miR-125a promoter regions. 
ESCs were treated with BMP4 for 1h and the samples were subjected to ChIP assay with 
the antibody against Smad1. The immunoprecipitated DNA was amplified by qPCR with 
primers detecting specific promoter regions denoted in the top panel. Data are expressed as 
fold enrichment relative to the untreated cells. * P < 0.05. 
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Figure 29. BMP4 regulates the level of miR-99b, without affecting miR-let7e level.  
The level of mature miR-let7e and miR-99b were detected by Taqman assay in ESCs 
treated with BMP4 for 24h. The data are expressed as miR-level normalized with U6 RNA. 
 
 
 
Figure 30. miR-99b ectopic expression doesn’t affect the differentiation program. 
ESCs transfected with the indicated pre-miR were differentiated as SFEBs for 4 days. The 
expression of stemness markers (Oct3/4, Nanog, Rex1) was analyzed by qPCR. The results 
are expressed as fold change relative to control.  
 
5. miR-125a maintains the epiblast phenotype during ESC 
differentiation 
We demonstrated that miR-125a overexpression maintains high levels of 
stemness markers at day 4 of SFEB differentiation, when in normal condition 
the cells have acquired a neuroectodermal phenotype (Sox1-positive) losing 
the stemness features. It is known that during SFEB differentiation the cells 
go through an intermediate stage, defined epiblast and corresponding to day 2 
of differentiation, when they start to be committed to a specific fate but are 
still pluripotent. Indeed, Epiblast stem cells (EpiSCs) still express some 
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stemness markers as Oct3/4 and Nanog, losing some others like Rex1. 
Moreover they are characterized by the expression of specific genes such as 
Fgf5, Dnmt3b and Cerberus. On this basis, we speculated that the expression 
of stemness markers could be associated to an epiblast phenotype. So, we 
analyzed the expression profile of epiblast markers during SFEB 
differentiation. In normal condition, they reach high level between day 1 and 
2 of differentiation. When miR-125a is overexpressed in ESCs, the expression 
of Fgf5, Dnmt3b and Cerberus is prolonged until day 4 of differentiation 
(Figure 31).  
 
         
 
 
Figure 31. miR-125a overexpression induces a prolonged expression of epiblast 
markers. 
ESCs were transfected with the indicated pre-miR and induced to differentiate through 
SFEB formation. Samples were collected at the indicated time points and analyzed by 
qPCR for the expression of epiblast markers (Fgf5, Cerberus, Dnmt3b). Data are expressed 
as fold change, calculated by assigning the arbitrary value, one, to the time point showing 
the highest amount of the indicated mRNA. * P < 0.05. 
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We analyzed also the epigenetic signature at Fgf5 transcriptional start site, 
after 4 days of SFEB differentiation, immunoprecipitating the chromatin with 
antibodies against H3K4-3me and H3K27-3me. We found that miR-125a 
overexpressing cells retain high level of H3K4-3me and low level of H3K27-
3me on this site (Figure 32), indicating that Fgf5 gene is still transcriptionally 
active at day 4 of differentiation.  
 
 
Figure 32. Fgf5 gene is still active at 4 days of SFEB differentiation upon miR-125a 
transfection. 
ESCs transfected with the indicated pre-miR were differentiated through SFEB formation. 
At 4 days of differentiation, the cells were immunoprecipitated with an antibody against 
H3K4-3me and H3K27-3me. The DNA was then amplified by qPCR with primers 
designed in the region of the transcriptional start site of Fgf5. Data are expressed as fold 
enrichment relative to control. * P < 0.05. 
 
 
6. miR-125a ectopic expression affects the transition through the 
epiblast stage during ESC differentiation 
An important difference between ESCs and EpiSCs is their dependence on 
extracellular factors: while ESCs require LIF and BMP4 for maintenance, 
EpiSCs depend on Nodal/Activin and Fgf2 signalling. Moreover the literature 
reports that BMP4 hampers the transition from ESC state to EpiSC state. 
Since miR-125a overexpression induces an active transcription of epiblast 
markers, even after their physiological expression window, we analyzed the 
status of Nodal/Activin signalling, crucial to sustain an epiblast phenotype. 
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We found a strong induction of Nodal/Activin targets (Cripto, Lefty1, Lefty2 
and Nodal) following miR-125a overexpression at day 4 of SFEB 
differentiation (Figure 33). Together with the previous observations, this 
result suggests that miR-125a could have a crucial role in the transition to 
epiblast state: following miR-125a overexpression, the reduced BMP4 
signalling could allow this transition; in addition, the increased activity of 
Nodal/Activin pathway could sustain EpiSC maintenance in this condition. To 
verify this hypothesis, we decided to downregulate the BMP4 signalling using 
a specific inhibitor of BMP receptor, dorsomorphin. Differentiating ESCs in 
presence of dorsomorphin we obtained the same phenotype of miR-125a 
overexpression: in particular, the maintenance of stemness and epiblast 
markers, associated to a reduction of neuroectodermal markers. Also the 
Nodal/Activin signalling resulted upregulated upon dorsomorphin treatment, 
showing that this pathway is strictly and inversely related to that of BMP4 
(Figure 34). 
 
 
Figure 33. miR-125a overexpression increases the activity of Nodal/Activin pathways 
during differentiation. 
The expression level of Nodal/Activin targets (Cripto, Lefty1, Lefty2, Nodal) was analyzed 
by qPCR in ESCs expressing miR-125a or miR-ctrl differentiated for 4 days as SFEBs. 
Data are reported as fold change relative to control. * P < 0.05. 
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Figure 34. The inhibition of BMP4 signalling impairs differentiation, maintaining the 
epiblast phenotype.  
ESCs were differentiated in presence of 2 µM dorsomorphin or DMSO as control. At 4 
days of differentiation, the phenotype was analyzed by immunostaining for Sox1 and 
Oct3/4 expression. Scale bar = 20 µm. Expression levels of stemness (Oct3/4, Nanog), 
neuroectoderm (Pax6), and epiblast (Fgf5, Nodal) markers, as well as BMP4 (Id1) and 
Nodal/Activin (Lefty2) targets were measured in the same samples. Data are expressed as 
fold change relative to control. * P < 0.05. 
 
 
To confirm that the persistence of epiblast markers means a permanence in 
the epiblast state, we transfected ESCs with pre-miR-125a or pre-miR-ctrl and 
differentiated them as SFEBs. We derived EpiSC-like cells dissociating the 
SFEBs and culturing the single cells in a specific epiblast medium for 5 days. 
Then we evaluated the number of colonies with an epiblast-like phenotype. 
Normally, the highest yield of EpiSC-like colonies is obtained at day 2 of 
SFEB differentiation, corresponding to the epiblast stage, and then it 
decreases. Since miR-125a overexpression maintains epiblast markers until 
day 4 of differentiation, we decided to derive EpiSCs at day 4 and 5 of 
differentiation, when in normal conditions it wasn’t possible. The figure 35 
shows that miR-125a overexpression gives an higher number of EpiSC-like 
colonies compared to the control, both at day 4 and 5 of differentiation. 
Moreover is evident that at day 5 of differentiation the yield of EpiSC-like 
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colonies strongly decreases also in miR-125a overexpressing cells, due to the 
lost of expression of miRNA, being transfected only transiently (Figure 36). 
We decided to check whether these EpiSC-like colonies have epiblast 
features. For this reason, we analyzed the expression of stemness and epiblast 
markers in EpiSC-like colonies derived from 4d differentiated SFEBs 
overexpressing miR-125a, compared to ESCs. We found that these colonies 
are actually EpiSCs, given the high expression of epiblast markers and the 
reduction (Oct3/4 and Nanog) or the lost (Rex1) of stemness markers (Figure 
37). To demonstrate that the persistence in epiblast state is actually due to the 
increase of Nodal/Activin signalling, we transfected ESCs with pre-miR-125a 
or pre-miR-ctrl and differentiated them in presence of Nodal/Activin receptor 
inhibitor, SB-431542. We found that the presence of SB-431542 prevented to 
derive EpiSC-like colonies from 4 and 5 day SFEBs overexpressing miR-
125a (Figure 38). So, the epiblast phenotype observed upon miR-125a 
overexpression requires Nodal/Activin signalling for maintenance.  
 
 
 
Figure 35. miR-125a overexpression allows to derive EpiSC-like colonies at later stage 
of SFEB differentiation. 
ESCs were transfected with pre-miR-125a or pre-miR-ctrl and induced to differentiate as 
SFEBs. Then, 4 and 5 day differentiated SFEBs were dissociated, plated in epiblast 
medium and grown for 5 days in these conditions. Only the large colonies faintly stained 
for AP were counted.  
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Figure 36. miR-125a overexpression during ESC differentiation. 
ESCs transfected with pre-miR-125a were differentiated as SFEBs. Mir-125a levels were 
measured by Taqman analysis at the indicated time points of differentiation. Data are 
expressed as relative level compared to the control. 
 
 
 
 
  
Figure 37. miR-125a overexpressing EpiSC-like colonies show epiblast features. 
Four day differentiated SFEBs, derived from ESCs transfected with miR-125a, were 
dissociated and plated in epiblast medium. The cells were grown for 5 days in this 
condition and then collected to analyze mRNA level of stemness (Oct3/4, Nanog, Rex1) 
and epiblast (Fgf5, Cerberus) markers. The expression of these genes in miR-125a 
overexpressing EpiSC-like colonies was compared to that of undifferentiated ESCs.  
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Figure 38. The epiblast phenotype depends on Nodal/Activin signalling for 
maintenance. 
ESCs were transfected with miR-125a and induced to differentiate as SFEBs in presence of 
10 µM SB-431542, the inhibitor of Nodal/Activin receptor, or DMSO as control. At 4 day 
of differentiation, SFEBs were dissociated and plated in epiblast medium. After 5 days of 
culture, the number of epiblast colonies was counted.  
 
 
 
7. The effects of miR-125a overexpression on epiblast transition are 
due to Dies1 suppression 
Being Dies1 a direct target of miR-125a, we analyzed the epiblast phenotype 
upon Dies1 suppression. As expected, we found that Dies1 suppression by 
shRNA strongly increases the expression of epiblast markers (Fgf5, Nodal, 
Otx2, Dnmt3b) and the activity of Nodal/Activin pathway (Lefty1, Lefty2, 
Cripto), at 4 days of SFEB differentiation (Figure 39). On this observation, 
we restored Dies1 level in ESCs overexpressing miR-125a and differentiated 
them for 4 days as SFEBs. We found that Dies1 was able to restore the proper 
level of epiblast markers and Nodal/Activin targets (Figure 40). This indicates 
that the epiblast phenotype induced by miR-125a overexpression is mediated 
by Dies1 suppression.  
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Figure 39. Dies1 suppression extends the epiblast stage during ESC differentiation. 
The levels of epiblast markers (Fgf5, Nodal, Otx2, Dnmt3b) and Nodal/Activin targets 
(Lefty1, Lefty2, Cripto) were assayed by qPCR in ESC transfected with shRNA against 
Dies1 (sh Dies1) or a control one (sh ctrl), at day 4 of SFEB differentiation. Data are 
expressed as fold change relative to control. * P < 0.05. 
 
 
 
 
Figure 40. Dies1 is able to rescue the epiblast phenotype. 
ESCs were co-transfected with the indicated pre-miR and vector expressing Dies1 lacking 
its 3’ UTR (Dies1) or the empty vector (mock). After 4 days of differentiation, the 
expression of epiblast markers (Fgf5, Otx2, Dnmt3b) and Nodal/Activin targets (Lefty1, 
Lefty2) was measured by qPCR. Data are expressed as fold change relative to control.  
* P < 0.05. 
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8. miR-125b overexpression impairs ESC differentiation maintaining 
an epiblast phenotype 
MiR-125b belongs to the same family of miR-125a but it is expressed at 
lower levels in ESCs than miR-125a. Then, its expression increases during the 
first steps of differentiation and reaches high levels in differentiated cells 
(Figure 41). In agreement, it is highly expressed in many adult mouse tissues 
(Figure 42).  
We have demonstrated that miR-125b, together with miR-125a, is able to 
regulate the expression of Dies1 modulating the BMP4 signalling, necessary 
in the differentiation fate of ESCs. So we decided to investigate whether also 
miR-125b could have a role in ESCs. First of all,  we analyzed the expression 
level of stemness markers (Oct3/4, Nanog, Klf4 and Klf5) in ESCs 
transfected with pre-miR-125b or pre-miR-ctrl, but we didn’t find difference 
in the undifferentiated condition (Figure 43).  
 
 
 
Figure 41. miR-125b expression in embryonic stem cells. 
miR-125b expression level was measured by qPCR in undifferentiated ESCs and during 
SFEB differentiation. The data are normalized to the U6 internal control. * P < 0.05. 
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Figure 42. miR-125b expression in adult mouse tissues. 
miR-125b expression level was measured by qPCR in the indicated adult mouse tissues. 
The data are normalized to the U6 internal control. * P < 0.05. 
 
 
 
Figure 43. miR-125b overexpression doesn’t affect the stemness of undifferentiated 
ESCs. 
ESCs were transfected with pre-miR-125b or pre-miR-ctrl. The level of stemness markers 
(Nanog, Oct3/4, Klf5, Klf2) was analyzed by qPCR. The data are reported as fold change 
relative to control. 
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To study the involvement of miR-125b in the early phases of differentiation, 
we differentiated ESCs expressing miR-125b or miR-ctrl, as SFEBs for 4 
days. At this time point, we found that overexpression of miR-125b, like of 
miR-125a, impairs differentiation, causing a reduction of Sox1 positive cell 
and an increase of Oct3/4 and Nanog positive cells (Figure 44). This result 
was confirmed by the analysis of expression profile of stemness (Oct3/4, 
Nanog) and differentiation (Pax6) genes (Figure 45). Moreover,  since the 
differentiation program is signed by the activation of Erk signalling, we 
checked the phosphorylation status of Erk by western blot assay, at day 4 of 
SFEB differentiation. According to the observed block of differentiation, 
miR-125b overexpression reduced the phosphorylated form of Erk protein 
(Figure 46). To understand whether the impairment of differentiation occurs 
before or after the transition to the epiblast state, we evaluated the expression 
level of epiblast markers during SFEB differentiation. We found that miR-
125b induces high level of Fgf5 at day 2 of SFEB differentiation, which 
remains significantly higher than control at day 4. The same trend was 
observed for Cerberus and Dnmt3b, whose levels were strongly increased 
following miR-125b overexpression, after four days of SFEB differentiation 
(Figure 47). To be sure that miR-125b blocks the differentiation in the 
epiblast stage, we analyzed the methylation status of epiblast markers. At day 
4 of SFEB differentiation, Nanog, Klf2 and Fgf5 genes were actually active 
upon miR-125b transfection, as indicated by the increase of H3K4-3me and 
the reduction of H3K27-3me (Figure 48). Coherently with the maintenance of 
epiblast markers, miR-125b overexpression caused an unbalance between 
BMP4 and Nodal/Activin signalling: indeed, BMP4 target genes (Id1 and Id3) 
were decreased, while those of Nodal/Activin pathway were upregulated 
(Figure 49). 
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Figure 44. miR-125b ectopic expression alters ESC neuronal differentiation. 
Markers of pluripotency (Oct3/4, Nanog) and neuroectoderm (Sox1) are shown in the 
immunofluorescence analysis of four-day differentiated SFEBs upon miR-125b 
overexpression. The percentage of positive cells on total cells is represented in the 
histogram. Scale bar = 50 μm. 
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Figure 45. miR-125b overexpression maintains stemness gene expression, impairing 
ESC differentiation. 
Expression profile of stemness (Oct3/4, Nanog) and neuronal (Pax6) markers was 
measured in undifferentiated ESCs and during SFEB differentiation, following pre-miR-
125b or control pre-miR transfection. Data are expressed as fold change, calculated by 
assigning the arbitrary value, one, to the time point showing the highest amount of the 
indicated mRNA. 
 
 
 
 
Figure 46. The activation of ERK signalling is impaired by miR-125b overexpression. 
ESCs transfected with pre-miR-125b or the control pre-miR were differentiated through 
SFEB formation for 4 days. In these samples, the level of active ERK (P-ERK) was 
analyzed by Western blot. Gapdh was used as loading control. 
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Figure 47. miR-125b expression maintains the epiblast phenotype. 
Samples of cells expressing mir-125b were collected in undifferentiated condition or 
during SFEB differentiation (2d, 4d). By qPCR assay, the level of Fgf5 was measured at 
these time points, while that of Cerberus and Dnmt3b was analyzed at 4 days of 
differentiation. Data are expressed as fold change.  
 
 
 
Figure 48. Stemness and epiblast marks are retained in miR-125b overexpressing 
ESCs. 
Chromatin from ESCs transfected with the indicated pre-miR and differentiated for 4 days 
as SFEBs was precipitated with antibody against H3K4-3me and H3K27-3me. The qPCR 
analysis was done using primers designed in the region of the transcriptional start site of 
stemness (Nanog, Klf2) and epiblast (Fgf5) genes. Data are expressed as fold enrichment 
relative to control. * P < 0.05. 
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Figure 49. miR-125b expression induces an unbalance between BMP4 and 
Nodal/Activin signalling. 
Upon miR-125b overexpression, the level of BMP4 (Id1, Id3) and Nodal/Activin (Nodal, 
Cripto, Lefty1, Lefty2) targets was analyzed by qPCR assay, at day 4 of SFEB 
differentiation. Data are expressed as fold change relative to the control. * P < 0.05. 
 
 
9. miR-125b overexpressing cells still retain their pluripotency in 
differentiating conditions 
We have demonstrated that miR-125b impairs differentiation maintaining the 
cells in an epiblast stage. To check whether these cells are actually 
pluripotent, we decided to perform a teratoma formation assay. To this aim, 
we transfected ESCs with pre-miR125b or pre-miR-ctrl and differentiated 
them as SFEBs. At  day 3 of differentiation, the cells were dissociated and 
injected into immunodeficient nude mice. After one month, we found that 
miR-125b overexpressing cells pre-differentiated in vitro for three days were 
able to form a teratoma in four of five injected mice, while the control 
transfected cells give a small teratoma only in one mice over five injected 
(Figure 50A). Moreover, the tumors were explanted and subjected to 
histological analysis by ematossilin/eosin staining, to evaluated their 
morphology. Tumors derived from miR-125b overexpressing cells were well 
differentiated; on the contrary the only one tumor derived from control cells 
was not completely differentiated (Figure 50B). Therefore, miR-125b 
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overexpressing cells are able to differentiate in vivo and to form a teratoma, 
indicating that they maintain their pluripotency even after 3 days of in vitro 
differentiation. 
 
Figure 50. miR-125b expressing cells differentiated in vitro are able to form a 
teratoma in immunodeficient mice. 
ESCs were transfected with the indicated miR and differentiated for three days in vitro. 
SFEBs expressing pre-miR-125b (right side) and pre-miR-ctrl (left side) were dissociated 
and injected into immunodeficient mice (A). Teratomas generated by cells overexpressing 
miR-125b were explanted after one month, and the tissues were analyzed after eosin-
hematoxylin staining (B). * P < 0.05.  
 
 
10.  miR-125b phenotype on the ESC-epiblast transition is due to Dies1 
We have previously shown that miR-125b regulates Dies1 expression in 
ESCs, modulating the BMP4 signalling. During SFEB differentiation, this 
results in the unbalance between BMP4 and Nodal/Activin signalling, 
facilitating the transition in the epiblast stage and the maintenance of this 
condition, impairing the neuroectodermal differentiation. We speculated that 
Dies1 could be responsible for the phenotype observed upon miR-125b 
overexpression. Thus, we transfected pre-miR-125b or pre-miR-ctrl together 
with a form of Dies1 insensitive to miR regulation. We found that at day 4 of 
74 
 
SFEB differentiation, Dies1 expression re-establishes the proper 
differentiation program (Figure 51), restoring the level of stemness and 
epiblast markers, as the activity of BMP4 and Nodal/Activin pathways 
(Figure 52).  
Recently, it was demonstrated that miR-125b targets Lin28 in ESCs to 
regulate mesendodermal differentiation. So, we measured the expression level 
of Lin28 in miR-125b overexpressing cells by Q-PCR and western blot 
assays. But at four days of SFEB differentiation, following miR-125b 
overexpression, Lin28 mRNA and protein don’t change demonstrating that 
they are not involved in the phenotype observed (Figure 53). 
 
 
Figure 51. Dies1 rescues the phenotype of ESC differentiation induced by miR-125b 
overexpression. 
Immunostaining of stemness (Oct3/4) and neuronal (Sox1) markers was performed on 
ESCs co-transfected with the indicated pre-miR and a vector expressing Dies1 lacking its 
3’ UTR (Dies1) and an empty vector (mock), at day 4 of SFEB differentiation. The 
histogram shows the percentage of positive cell for the indicated marker on total cells.  
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Figure 52. Dies1 restore the proper SFEB differentiation program. 
The level of stemness (Oct3/4, Nanog) and epiblast (Fgf5) markers, such as the level of 
BMP4 (Id1) and Nodal/Activin (Lefty1, Lefty2) targets were measured by qPCR in ESCs 
co-transfected with the indicated pre-miR and a vector expressing Dies1 lacking its 3’ 
UTR (Dies1) and an empty vector (mock), at day 4 of SFEB differentiation. Data are 
expressed as fold change relative to the control. * P < 0.05.  
 
 
 
 
 
Figure 53. miR-125 isoforms do not target Lin28 protein in undifferentiated ESCs. 
ESCs transfected with the indicated pre-miR were differentiated as SFEBs. Following four 
days, the level of Lin28 was checked in these samples by qPCR and Western blot assay.  
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11.  Suppression of miR-125a and miR-125b promotes ESC 
differentiation 
Given the phenotype induced by miR-125a or miR-125b in ESC 
differentiation, we asked whether their reduction could alter the 
differentiation program. Thus, we suppressed both miR-125a and miR-125b 
in ESCs using a mix of the specific anti-miR, to avoid that one of them could 
substitute for the other sharing the same targets. Then, the transfected cells 
were grown at low density in presence of LIF and assayed for AP staining 
after 7 days. We found that the suppression of both miRNAs reduces 
significantly the number of AP positive colonies compared to the control, 
suggesting that the miR-125a and b suppressed cells are losing the 
undifferentiated phenotype (Figure 54). To support this finding, we showed 
that, upon miR-125a and miR-125b suppression, Oct3/4 expression starts to 
decrease just at day 2 of SFEB differentiation and this is more evident at day 
4 of differentiation, indicating that the reduction of miR-125a and miR-125b 
accelerates the differentiation program (Figure 55). 
Since we demonstrated that Dies1 is a target of miR-125a and miR-125b, we 
speculated that Dies1 overexpression should phenocopy the miRNA 
suppression. Indeed, we showed that the ectopic expression of Dies1 in ESCs 
grown at low density in presence of LIF gives a lower number of the AP 
positive colonies than control transfected cells (Figure 56). This result 
confirms the strong correlation between Dies1 and miR-125a/miR-125b role 
in ESCs.  
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Figure 54. miR-125a and miR-125b suppression induces the lost of stemness 
phenotype. 
miR-125a and miR-125b downregulated ESCs (anti-miR-mix) were grown in clonal 
condition in presence of LIF for 7 days. The stemness was assayed by staining for Alkaline 
Phosphatase (AP). The histogram reports the percentage of positive and negative colonies. 
* P < 0.05. 
 
 
 
 
Figure 55. The expression of Oct3/4 is lost earlier during differentiation, following 
suppression of miR-125a and miR-125b. 
Upon miR-125a and miR-125b suppression, ESCs were differentiated as SFEBs. Oct3/4 
expression was measured by qPCR on samples collected at day 2 and 4 of differentiation. 
Data are expressed as fold change relative to control. * P < 0.05. 
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Figure 56.  Dies1 ectopic expression allows ESCs to spontaneously differentiate. 
ESCs overexpressing Dies1 after seven days of culture at clonal density in the presence of 
LIF were stained with Alkaline Phosphatase (AP). The percentage of AP positive and 
negative colonies is reported in the graph. * P < 0.05. 
 
 
12. The regulation of miR-125b expression is independent from TGFβ 
signalling 
We have demonstrated that miR-125a expression is under the transcriptional 
control of BMP4 signalling. In ESC differentiation, miR-125b gives the same 
phenotype of miR-125a, targeting Dies1 and affecting the same signalling 
pathway. The presence in ESCs of two miRNAs belonging to the same family 
and sharing the role in ESC fate determination, seems to be an unnecessary 
redundancy. But we supposed that a difference should exist and it could 
concern the miRNA regulation. To test this hypothesis, we analyzed the level 
of miR-125b in ESCs upon BMP4 treatment. Contrary to miR-125a, miR-
125b precursor and mature levels were not affected following the treatment. 
The same result was obtained treating ESCs with Activin indicating that miR-
125b is not regulated by these pathways (Figure 57).  
Moreover, we decided to investigate whether this independence from TGFβ 
signalling was restricted to ESCs or it can be a general mechanism. We used 
the C2C12 cell line, where miR-125b was demonstrated to play a role in the 
differentiation program (Ge, et al., 2011), as the BMP4 pathway (Dahlqvist, et 
al., 2003). We found that miR-125b was actually expressed in these cells and 
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at 4 days of differentiation (Figure 58). Then, we evaluated the level of 
mature miR-125b but we didn’t find any difference following BMP4 
stimulation (Figure 59). This observation indicated that  miR-125b controls 
BMP4 signalling, through Dies1, but is not regulated by this cytokine.  
 
 
           
Figure 57. miR-125b regulation is independent from TGF-β signalling. 
ESCs were treated with BMP4 or Activin. 1h after the stimulation, the level of pri-miR 
was analyzed by qPCR using specific primers that distinguish between the transcripts 
deriving from the two miR-125b genes (pri-miR-125b-1 and pri-miR-125b-2) (A). The 
mature form of miR-125b was measured by Taqman assay at 24h from the induction (B). 
Data are expressed as fold change relative to control. 
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Figure 58. miR-125b expression in C2C12 myoblasts. 
Expression level of miR-125b was evaluated in undifferentiated and 4d differentiated 
C2C12 by Taqman analysis. Data are expressed as fold change relative to control. 
 
 
 
Figure 59. miR-125b level is not controlled by BMP4 in C2C12 myoblasts. 
miR-125b expression was analyzed in C2C12 treated with BMP4 for 24h. Data are 
expressed as fold change relative to control.  
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Discussion 
To unravel the mechanisms controlling ESC fate is an important goal for ESC 
application in regenerative medicine. Despite the growing number of studies 
in this field, a lot has still to be discovered and clarified.  
Recently, it was identified a new gene involved in BMP signalling and in ESC 
differentiation, named Dies1 (Aloia, et al., 2010). Considering its role in ESC 
differentiation, we searched for Dies1 regulators that could physiologically 
modulate its expression during ESC fate decision and thus the cell sensitivity 
to BMP4 response. We speculated that this could be one of the regulatory 
mechanisms of ESC differentiation. So, we decided to explore the possibility 
of a post-transcriptional regulation of Dies1 by miRNAs, given their 
established role in the regulation of protein expression at post-transcriptional 
level. Here we demonstrate that Dies1 is a direct target of both miR-125a and 
miR-125b. These miRNAs are expressed in undifferentiated ESCs, where the 
level of miR-125b is lower than miR-125a. Their expression remains almost 
constant until day 4 of SFEB differentiation, and reaches higher level in 
differentiated cells. The involvement of these miRNAs in ESCs was 
previously demonstrated by other groups. In particular, miR-125a was found 
to down-regulate the RNA binding protein Lin28, after 6 days of 
differentiation as embryo bodies, when the concentration of miR-125a is very 
high and that of Lin28 goes down (Zhong, et al., 2010). Wang and 
collaborators showed that also the miR-125b negatively regulates 
mesendodermal commitment of ESCs through direct targeting of Lin28, but 
without affecting ectodermal lineage (Wang, et al., 2012). The role of these 
miRNAs was investigated also in human ESCs. miR-125 isoforms were 
demonstrated to promote neural differentiation of hESCs by avoiding the 
persistence of non-differentiated stem cells and repressing alternative fate 
choices. This phenotype was associated with the regulation by miR-125 
isoforms of SMAD4, a key regulator of pluripotent stem cell lineage 
commitment (Boissart, et al., 2012). The region of Smad4 mRNA targeted by 
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miR-125a and miR-125b in hESCs is not conserved in the mouse gene, 
indicating that the phenomenon observed in hESCs is species-specific.  
Here, we demonstrate that miR-125a and miR-125b ectopic expression 
doesn’t affect the undifferentiated condition of mouse ESCs, while it impairs 
the early steps of mouse ESC neuronal differentiation, as Dies1 suppression 
does. Moreover the phenotype observed can be rescued at least in part by 
Dies1 re-expression in ESCs, indicating that miR-125a and miR-125b can 
participate at ESC differentiation program acting at different level, 
modulating the expression of specific target at specific time point.  
The target of miR-125a and miR-125b, Dies1, has an important role in BMP4 
pathway, acting as AlK3 co-receptor. This observation is supported by our 
FRET/FLIM data showing that Dies1 can interact at molecular level with the 
BMP4 receptor, Alk3. It is known that this signalling depends on different co-
receptors for working, and Dies1 could represent a new regulatory co-receptor 
involved in the signal transduction in ESCs. More recently, another group 
have proposed a new function of Dies1 (that they called VISTA). They found 
that Dies1 is mostly expressed on hematopoietic tissues (spleen, thymus, and 
bone marrow) or tissues with ample infiltration of leukocytes (lung). Weak 
Dies1 expression was also detected in non-hematopoietic tissues (heart, 
kidney, brain, ovary). Analysis of several hematopoietic cell types revealed 
expression of Dies1 on peritoneal macrophages, splenic CD11b+ monocytes, 
CD11c+ dendritic cells, CD4+ and CD8+ T cells, but a lower expression level 
on B cells (Wang, et al., 2011). They have suggested Dies1/VISTA as a new 
member of the Ig superfamily network, which exerts immunosuppressive 
activities on T cells both in vitro and in vivo and could be an important 
mediator in controlling the development of autoimmunity and the immune 
responses to cancer (Wang, et al., 2011). This function could seem unrelated 
to that in ESCs. Actually, some data indicates that ESCs are able to inhibit T-
cell activation and the immune response in vivo, at least in part due to the 
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production of TGF-β (Koch, et al., 2008). A possible involvement of Dies1 in 
this context needs to be deeply explored. 
It’s known that BMP4 have different roles in different stage of ESC 
differentiation (Zhang, et al., 2010). In undifferentiated ESCs, BMP4 
contributes to stemness maintenance, mostly by blocking the transition of 
ESCs to the epiblast stage. In EpiSCs, it prevents the differentiation toward 
the neuroectodermal fate, favouring mesodermal lineage. 
We have shown that miR-125 isoforms downregulate the BMP4 signalling, 
inducing a concomitant increase of Nodal/Activin pathway, as Dies1 
suppression does. The alteration of these signal transduction pathways leads 
to an impairment of ESC differentiation. In particular, miR-125a and miR-
125b overexpression facilitate the transition of ESCs to epiblast state, due to  
the reduction of BMP4 signalling, which normally opposes this progression. 
At the same time, the increase of Nodal/Activin pathway sustains the 
permanence of the epiblast phenotype, until miR-125a and miR-125b ectopic 
expression levels are maintained. The role of BMP4 pathway in the epiblast 
transition is supported by data obtained from the ESC treatment with 
dorsomorphin, a BMP4 receptor inhibitor. In this condition, ESCs cannot 
properly differentiate, giving a phenotype very similar to that observed upon 
miR-125a and miR-125b overexpression, like the persistence of epiblast state. 
It is known that EpiSCs can be derived and cultured in a medium containing 
Nodal/Activin, and their expansion depends on this signalling (Brons, et al., 
2007). Moreover, Zhang and co-workers demonstrated that it is possible to 
derive an epiblast population from ESCs differentiated as SFEBs. The higher 
yield of EpiSC-like colonies is obtained at day 2, corresponding to the 
epiblast stage, while later during differentiation this is strongly reduced 
(Zhang, et al., 2010). We demonstrated that EpiSC-like colonies can be 
derived from miR-125a overexpressing ESCs differentiated for 4 and 5 days  
as SFEBs. Moreover, we confirmed the literature data indicating that the 
derivation of EpiSC-like colonies depends on the Nodal/Activin signalling. 
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Indeed, the EpiSC-like colony derivation from miR-125a overexpressing 
ESCs differentiated for 4 and 5 days  as SFEBs is impaired by the addition of 
Nodal/Activin receptor inhibitor, SB-431542, suggesting that it is necessary 
for the maintenance of the epiblast phenotype. All these data indicate that a 
fine balance between BMP4 and Nodal/Activin pathways is necessary to 
correctly induce the progression to the epiblast stage. As other studies 
demonstrated, EpiSCs still retain their pluripotency. We demonstrated that 
mir-125b overexpressing ESCs, pre-differentiated in vitro, have the ability to 
induce, in vivo, the formation of a fully differentiated teratoma. This result 
confirm that the overexpression of miR-125a and miR-125b actually impairs 
differentiation, blocking EpiSCs progression toward the various 
differentiation fate. 
Given the effects of miR-125 isoforms on ESC differentiation, we decided to 
investigate also the suppression of both miRNAs. Coherently we found that 
miR-125a and miR-125b depletion in ESCs induces a loss of undifferentiated 
state in presence of LIF, such as an early turn off in the expression of 
stemness markers during differentiation. It’s interesting that also this aspect is 
phenocopied by Dies1 ectopic expression, further supporting the correlation 
between this gene and miR-125a and miR-125b in ESCs.   
Dies1 plays an important role in BMP4 signalling and its expression is 
regulated by miR-125 isoforms at post-transcriptional level. So, we wondered 
whether the miRNA expression could be controlled by BMP4 signalling. We 
demonstrated that BMP4 stimulation induces the expression of miR-125a, 
recruiting Smad1 on its promoter. The miRNA, in turn, targets Dies1 mRNA 
modulating BMP4 signalling and generating a feedback regulatory loop 
which sets the cell sensitivity to BMP4. This could represent an important 
mechanism in the ESC environment where the extracellular signalling play a 
key role in determining the cell identity. miRNA 125a gene is localized on 
mouse chromosome 17 clustered with miR-99b and Let-7e. Since they have a 
common promoter region, we checked whether also these others are regulated 
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by BMP4. We found that Let7e is not responsive to BMP4 stimulation, while 
miR-99b expression is increased following the treatment. Nevertheless, its 
overexpression in ESCs didn’t induce any obvious change in ESC 
differentiation.  
miR-125b belongs to the same family and gives the same phenotype of miR-
125a in ESC differentiation. Even if it could appear as an unnecessary 
redundancy, we found that the BMP4 regulation demonstrated for miR-125a 
was not observed for miR-125b. Indeed, this gene is not responsive to BMP4 
stimulation, neither to Nodal/Activin one. The independence from TGF-β 
signalling regulation is not restricted to ESCs, but is a more general event, 
since the same was confirmed in C2C12 myoblasts, where miR-125b has a 
function during  myogenic differentiation. 
In summary, our data demonstrate that in the first steps of ESC 
differentiation, in particular in the transition to the epiblast stage, the BMP4 
signalling undergoes different regulations that are dependent (miR-125a) or 
independent (miR-125b) by BMP4 itself, but both are mediated by Dies1 
function (Figure 60). This finding unveils the presence of different ways that 
can participate in the modulation of BMP4 signalling in ESCs. Moreover, the 
close link between Nodal/Activin and BMP4 pathways is strengthened as one 
of the mechanisms governing the timing and the execution of the early steps 
of ESC and EpiSC differentiation. 
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Figure 60. Schematic representation of the BMP4 regulation by miR-125a and miR-
125b through Dies1. 
In ESCs, the activity of BMP4 signalling is modulated by miR-125a and miR-125b, both 
regulate Dies1 expression. At the same time, miR-125a level is under the control of BMP4 
pathway itself, generating a negative feedback loop. Instead miR-125b expression is 
independent from TGF-β signalling. 
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Appendix 1. Primers used for cloning 
Name Forward primer Reverse primer 
Dies1 
3'UTR 
GCCTGACCTGTCTCCAGCCCTAAGC
TTCAGACCTCACCACTCAG 
 
GCACTCGGTACCTTATCAACTGTATC
CTTAGCAGAATTCCTC 
Dies1 
mut 
3'UTR 
 
GGGAGCTGAACTAAAAATTTGACA
CGTGACTAAAATAGGCAAAAGAGG 
 
CCTCTTTTGCCTATTTTAGTCACGTGT
CAAAT 
TTTTAGTTCAGCTCCC 
Dies1-
EGFP 
 
GCCGAAGCTTGGCGGAGGTGTGAG
CAAGGGCGAGGAGCTGTTCACCGG
GGTGGTGCCC 
 
GCGTGAGCGGCCGCCCGCTTTACTTG
TACAG 
CTCGTCCATGCCGAGAGTG 
Alk3 
 
CAGCGGATCCGCCGCCATGACTCA
GCTATACACTTACATCAGATTAC 
 
GCCAAGCTTAATCTTTACATCCTGGG
ATTCAA 
C 
Alk3-
Cherry 
 
GCCGAAGCTTGGCGGAGGTGTGAG
CAAGGGCGAGGAGGATAACATGGC
CATCATCAAGG 
 
GAGTCGCGGCCGCTACTTGTACAGCT
CGTCC 
 
 
Appendix 2. Primers used for Real-Time PCR 
Name Forward primer Reverse primer 
Alk3  CTCATGTTCAAGGGCAGAATCTAG TTTCTGGCTTCTTCTGGTCCAA 
Cerberus ACTGTGCCCTTCAACCAGACCATTG TGCCCCTTCTCCGGGAAAACGA 
Cripto ATCCAGTGTGGTTTTGCTTGTG TCTCTGATGGCAAGGTCTCTCC 
Dies1  GCAGGCAAAGGCTCGGGGTC CCGCAGCCGTGATGCTGTCA 
Dnmt3b CCAAGGACACCAGGACGCGC TCCGAGACCTGGTAGCCGGAA 
Fgf5 CCTCATCTTCTGCAGCCACCTGATC GTTCCGAGCCGCTTCCTTGGCTGCC 
Gapdh  GTATGACTCCACTCACGGCAAA TTCCCATTCTCGGCCTTG 
Id1  GAGCAGCAGGTGAACGTCCT TCCTTGAGGCGTGAGTAGCA 
Id3  GTAAGAGCCCGTCGACCGA GCAGTGGTTCATGTCGTCCA 
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Klf2  CCAACTGCGGCAAGACCTAC CAATGATAAGGCTTCTCACCTGTGT 
Klf5  GGTCCAGACAAGATGTGAAATGG TTTATGCTCTGAAATTATCGGAACTG 
Lefty1  CTCGGGTCACCATTGAATGG TGGACACGAGCCTAGAATCGA 
Lefty2  GTCACCATTGAATGGCTGAGAG GTGGATGGACACGAGCCTAGAG 
Lin28  GTTCGGCTTCCTGTCTATGACC CTTCCATGTGCAGCTTGCTCT 
Map2  AACGGGATCAACGGAGAGCT TTGACTACTTGAACTATCCTTGCAGAT 
Nanog  TCAGAAGGGCTCAGCACCA GCGTTCACCAGATAGCCCTG 
Nodal  CCTCCAGGCGCAAGATGT ACCAGATCCTCTTCTTGGCTCA 
Oct3/4  AACCTTCAGGAGATATGCAAATCG TTCTCAATGCTAGTTCGCTTTCTCT 
Otx2  CATGATGTCTTATCTAAAGCAACCG GTCGAGCTGTGCCCTAGTA 
Pax6 AGTGAATGGGCGGAGTTATG ACTTGGACGGGAACTGACAC 
pri-miR- 
125b-1 
GAGTCTGCAACCGAAATTGCCTG GTTCCTTCAGCGATGCAAAGGC 
pri-miR- 
125b-2 
GCTGTCCGTTTACCTGGAAGAAG CTGGTGGTTTATGCCGAGAATC 
Rex1  GCAGTTTCTTCTTGGGATTTCAG CTAATGCCCACAGCGAT 
Sox1  CATCTCCAACTCTCAGGGCT ACTTGACCAGAGATCCGAGG 
Sox2  CTGCAGTACAACTCCATGACCAG GGACTTGACCACAGAGCCCAT 
up  GGTGACCCCTGGCAACCTTCCT TCATTGTGGGGGAGGGGGAGC 
dw  TGAGGCATCTCCTGGTTCCTTTCT TCCCCAGAGGTGGGAACGGG 
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Appendix 3. Primers used for ChIP 
Name Forward primer Reverse primer 
1 ACCCGAAGGAGAATGCTCTGTGT TCATCTCAGCAGCTTGCCCTGGGGA 
2 CACTTGACGCCCAGGGGCTG  GCCTTGAAACTCAGGACCCAGCA 
3 ACCAAGCCCTAGTGAGCTGAGGT  TGGAGTCAAAGTCAGGGCCTCGT 
4 TGCTGAGTGATTTGCAGCTGCCT  GCCCACAGAGACAAGGAGAGGG 
5 AACACGTTCGGGACTGCCCG  AGGGACCAAGAGACCGGAAGCT 
6 GGGGAGGAACACTGCGCAGG  CCAGGGGCTGCATTTCCACCC 
7 AGGGTCCCCAAGGGAGGAGG  CCACCACCACTTCGCTATCC 
8 ACCAGGTTTCCCCCACCCC  TGGTCCCGCCCCCTTAACCC 
9 TCTGCCGGGGAGGGCTATGG  CCCTGCCGCCTTGCACTCAA 
10 TTCAGGGCATCCACGTGGGC  TGGCAGACACGGAGGCGTTC 
Fgf5  AGGGACGGTCAAGATTCCTT AGAACCAGCAGAGTCCCAGA 
Klf2  TGCAGATCTTGAGGGCCTAGTTGT TCCCATGGAGAGGATGAAGTCCAA 
Oct3/4  GGACTAGAACCCAGAATTGCAAGA GTACAGACAGTGATGGCATGAAGC 
Nanog  TGTGAGCTCAGTGCTCCTTCCAAA TTCAGACCTTGGCTCCAGATGCTA 
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